Total Internal Reflection - Fluorescence Correlation Spectroscopy (TIR-FCS): Application to the Study of Ligand - Receptor Interactions by Navaratnarajah, Punya
  
Total Internal Reflection – Fluorescence Correlation Spectroscopy 
(TIR-FCS): Application to the Study of Ligand – Receptor 
Interactions 
 
 
Punya Navaratnarajah 
 
 
A dissertation submitted to the faculty of the University of North Carolina at 
Chapel Hill in partial fulfillment of the requirements for the degree of Doctor of 
Philosophy in the Department of Biochemistry and Biophysics. 
 
 
Chapel Hill 
2012 
 
 
 
Approved by: 
 
Kenneth A. Jacobson, PhD 
 
Gerhard Meissner, PhD 
 
Matthew R. Redinbo, PhD 
 
Nancy L. Thompson, PhD 
 
Richard V. Wolfenden, PhD 
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
©2012 
Punya Navaratnarajah 
ALL RIGHTS RESERVED 
iii 
 
 
 
ABSTRACT 
 
PUNYA NAVARATNARAJAH: Total Internal Reflection – Fluorescence Correlation 
Spectroscopy (TIR-FCS): Application to the Study of Ligand – Receptor Interactions 
(Under the Direction of Nancy L. Thompson) 
 
Ligand-receptor interactions are an integral part of cellular processes.  Fully 
understanding these processes requires that the thermodynamic and kinetic parameters of 
ligand-receptor interactions be measured.  Total internal reflection fluorescence 
microscopy combined with fluorescence correlation spectroscopy (TIR-FCS) can be used 
to characterize the interactions between a fluorescent ligand and surface-associated 
receptors.  The overall objective of this work was to develop TIR-FCS so as to ease its 
implementation, and expand its application to the study of complex ligand-receptor 
systems. 
Theoretical models describing ligand-receptor interactions measured by TIR-FCS 
depend on numerous parameters, which complicate the identification of optimal 
experimental conditions.  Criteria, that, if satisfied, would yield autocorrelation curves 
containing significant information about the kinetics, were defined.  Parameter space was 
systematically explored to identify experimental conditions that satisfy the criteria. 
Theoretical work has indicated that TIR-FCS curves contain information about 
nonfluorescent species that associate with receptors and, thereby, alter the interaction of 
receptors and fluorescent reporter-ligands.  Two nonfluorescent species were defined: 1) 
nonfluorescent effectors (NE) allosterically enhance or inhibit the binding of fluorescent 
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ligand and receptors; while 2) nonfluorescent competitors (NC) compete with fluorescent 
species for receptors.  To test these theoretical predictions, work was conducted to 
establish systems consisting of a NE and NC. 
The pregnane X receptor (PXR), a transcription factor, peptides derived from co-
activator and co-repressor proteins and a PXR ligand, rifampicin, were chosen to test NE 
theory.  It was found that, contrary to the existing model of PXR action, rifampicin fails 
to allosterically enhance and reduce PXR’s affinity for co-activator and co-repressors, 
respectively.  The biological significance of these results is discussed.  These findings 
preclude the system from being used to test NE theory.  As co-activators and co-
repressors compete for PXR, the system can be used to test NC theory. 
An IgG and Fc receptor, FcγRII, were initially chosen to test NC theory.  Peptides 
derived from the antibody binding site on FcγRII were tested to identify those that 
compete with soluble FcγRII for surface-bound IgG.  A poorly soluble peptide that 
performs this function was identified.  An improvement in solubility is required if the 
system is to be used to test NC theory. 
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Chapter 1 
 
Introduction 
 
1.1 Overview 
A comprehensive mechanistic understanding of biochemical processes requires 
that the thermodynamic and kinetic parameters pertaining to the interaction of relevant 
biological molecules be measured.  Several techniques, including isothermal calorimetry 
and surface plasmon resonance, allow for such measurements.  A fluorescence 
microscopy-based technique, total internal reflection – fluorescence correlation 
spectroscopy (TIR-FCS), can also be used to study the thermodynamics and kinetics of 
interacting molecules.  TIR-FCS and variations thereof have the advantage that that they 
are versatile and amenable to live cell imaging, yielding both thermodynamic and spatio-
temporal information.  The focus of the present work has been the development of TIR-
FCS for its application towards the thermodynamic and kinetic characterization of 
fluorescent molecules in solution that reversibly interact with surface-bound, non-
fluorescent molecules.  In practical terms, this work facilitates the adoption of the 
technique to study the interaction between soluble ligands and membrane-bound 
receptors, as well as the interaction between soluble biological molecules where at least 
one of the interacting partners is amenable to surface-immobilization. 
Sections 1.2 – 1.4 reproduced with permission from: Thompson, N. L., Navaratnarajah, P., Wang, 
X. Reviews in Fluorescence 2009; Geddes, CD, Ed.; Springer: New York; pp 345-380.  
Copyright 2011 Springer. 
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1.2 Total Internal Reflection Fluorescence Microscopy (TIRFM) 
 TIR-FCS combines two well established techniques, total internal reflection 
fluorescence microscopy (TIRFM) and fluorescence correlation spectroscopy (FCS).  In 
TIRFM (1-3), evanescent illumination is used to specifically excite fluorescently labeled 
molecules that are in close proximity to a surface, usually an aqueous/glass interface.  
Briefly, when light traveling in a medium with refractive index n1 impinges on an 
interface with a lower refractive index (n2) medium, at an angle greater than the critical 
angle, αc, where 
 12
1sin nnc
 ,         (1.1) 
the light is completely reflected back into the first medium in a process called total 
internal reflection.  During TIR, a component of the incident light propagates parallel to 
the TIR interface and penetrates into the lower refractive index medium, where the 
intensity, I(z), decays exponentially with increasing distance, z, from the interface: 
  dzeIzI  0 .          (1.2) 
The depth, d, of this exponentially decaying evanescent wave is determined by the 
vacuum wavelength of the incident light, λ0, the angle of incidence, α, and refractive 
indices, n1 and n2: 
2
2
22
1
0
sin4 nn
d




.        (1.3) 
The depth of the evanescent wave is typically on the order of 100 nm, and only those 
fluorescently labeled molecules within this depth are likely to be excited. 
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1.3 Fluorescence Correlation Spectroscopy (FCS) 
 As fluorescently labeled molecules diffuse in and out of the observation volume, 
the fluorescence signal fluctuates.  The temporal pattern of these fluorescence 
fluctuations is altered if the molecules reversibly interact with surface binding sites, for 
instance, impeding their ability to freely diffuse.  FCS (4-9) can be used to measure the 
temporal pattern of fluorescence fluctuations and, thereby, gain insight into the dynamics 
of the fluorescent species being studied.  Towards this end, fluctuations in the 
fluorescence signal, defined as the difference   tF  between the instantaneous 
fluorescence, F(t), and the time-averaged fluorescence, F , are autocorrelated as a 
function of the lag-time,  , using the following equation: 
 
   
2
F
tFtF
G



 .        (1.4) 
The autocorrelation function,  τG , is independent of the time, t, when the system of 
interest is at equilibrium.   τG  decays to zero as   approaches infinity.  The magnitude 
of this function is inversely related to the average number of fluorescent molecules in the 
observation volume.  The rate of decay and shape of  τG  contain information about the 
processes that affect the pattern of fluorescence fluctuations, including photo-physical 
dynamics (e.g., triplet state kinetics), solution diffusion, association and dissociation with 
surface-binding sites, and/or enzyme kinetics. 
As FCS monitors the deviation of the instantaneous fluorescence from the time-
averaged fluorescence, recording the fluorescence emanating from a large number of 
fluorescent molecules will only yield ensemble-averaged fluorescence measurements and 
fluorescence fluctuation autocorrelation functions that are small in magnitude.  To obtain 
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autocorrelation functions with magnitudes large enough to be accurately measured, the 
average number of fluorescent molecules in the observed volume has to be small.  Most 
FCS measurements are carried out with at most 100 fluorescent molecules in the 
observed volume.  One way to reduce the average number of fluorescent molecules in the 
observation volume, other than by simply decreasing the concentration, is to reduce the 
size of the detection volume. 
1.4 Total Internal Reflection – Fluorescence Correlation Spectroscopy (TIR-FCS) 
TIR-FCS (10-12) is used to study the dynamics of fluorescent molecules at 
surfaces (Figure 1).  Apart from conferring surface selectivity, TIR illumination serves to 
reduce the size of the observation volume via axial confinement and lower the 
background signal (13).  However, evanescent illumination does not reduce the detection 
volume sufficiently to achieve an acceptable number of fluorescent molecules in the 
observation volume for FCS.  Therefore, a circular pinhole (14, 15) or fiber optic cable 
(16, 17) placed at a back image plane of the microscope is used to achieve lateral (x-y 
sample plane) confinement that reduces the observed area to about 1 µm
2
.  A schematic 
of the particular TIR-FCS set up we employ is shown in Figure 1.1. 
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Figure 1.1: Through-Prism TIR-FCS.  (a) A laser beam is totally internally reflected at a 
sample plane through a prism that is mounted on the stage of an inverted microscope.  (b) An 
evanescent wave of depth d excites fluorescence, which is collected through the high-aperture 
objective and passed through a spectral filter to remove scattered evanescent light.  The light is 
passed through a small aperture, placed at a back image plane of the microscope, before reaching 
a single-photon counting detector.  The detector signal is processed using a computer with a 
correlator card and associated software.  Reproduced with permission from J. Struct. Biol. 2009. 
168, 95-106. 
 
In TIR-FCS fluorescence fluctuations arising from fluorescent species that move 
in and out of the detection volume, undergo photophysics and/or reversibly associate with 
the surface are autocorrelated (Figure 1.2).  Measured autocorrelation functions are fit to 
theoretical models derived for a given system, to obtain values of the parameters of 
interest.  These theoretical autocorrelation functions take into account the optical 
arrangement of the excitation and emission pathways, as well as the processes giving rise 
to the observed fluorescence fluctuations.  Many different theoretical models have been 
described in the literature: triplet state kinetics (18); diffusion in the evanescent field (20-
24); ligand-receptor kinetics (25, 26); enzyme kinetics (27); cross-correlation TIR-FCS 
(28); and other situations (16, 17, 29, 30). 
(a) (b) 
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Figure 1.2:  Fluorescence Fluctuation Autocorrelation Functions.  (a) The fluorescence 
measured from the observation volume fluctuates with time as individual fluorescent molecules 
diffuse through the evanescent field, associate with and dissociate from surface binding sites, 
and/or undergo transitions between states with different detected fluorescence intensities.  (b) The 
temporal fluorescence fluctuations are autocorrelated (see Eq. 1.4). This plot shows an idealized 
case in which three components with different characteristic rates are present in G(τ); e.g., a very 
fast decay arising from photophysics, a fast decay arising from free diffusion of the fluorescent 
molecules through the depth of the evanescent field, and a slow decay resulting from reversible 
association of the fluorescent molecules with surface sites.  Reproduced with permission from 
Reviews in Fluorescence 2009; Geddes, CD, Ed.; Springer: New York; pp 345-380. 
 
1.5 Outline of Dissertation 
In the present work we are concerned with the extension of TIR-FCS to the study 
of ligand-receptor kinetics.  This particular application of TIR-FCS was first 
demonstrated when the technique was used to examine the kinetics of the mouse Fc 
receptor, FcγRII, and an IgG (14).  To conduct these measurements, FcγRII was 
reconstituted in supported planar membranes deposited on fused silica microscope slides, 
while the antibody was fluorescently labeled and introduced into the aqueous medium 
between the microscope slide and cover slip.  TIR-FCS was used to measure the 
fluorescence fluctuations that arose as fluorescently labeled antibodies diffused in and out 
of the observation volume, and reversibly associated with surface-bound FcγRII.  These 
fluorescence fluctuations were autocorrelated and fit to a theoretical model describing 
ligand-receptor kinetics to obtain the dissociation rate constant.  The autocorrelation 
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curves obtained for ligand-receptor interactions contained a long-time component that is 
absent when the fluorescence fluctuations arise due to diffusion alone (Figure 1.3). 
Figure 1.3: IgG Dynamics.  (a) Schematic of antibody diffusion close to a supported planar 
membrane.  Fluorophores within the evanescent wave are excited and fluoresce.  (b) 
Representative TIR-FCS data and the best fit to an appropriate theoretical expression.  The data 
are for a mixture of 10 nM Alexa448-labeled IgG, 1 μM unlabeled IgG and 10 mg mL-1 
ovalbumin in phosphate-buffered saline close to surfaces coated with supported phospholipid 
bilayers.  (c) Schematic of antibodies diffusing close to and reversibly associating with a 
supported planar membrane containing purified and reconstituted Fc receptors.  The parameters 
ka and kd are the association and dissociation rate constants, respectively.  d) Representative TIR-
FCS data and the best fit to an appropriate theoretical expression.  The data are for a mixture of 
10 nM Alexa448-labeled IgG, 1 μM unlabeled IgG and 10 mg mL-1 ovalbumin in phosphate-
buffered saline close to surfaces coated with supported phospholipid bilayers containing 
approximately 800 receptors per μm2.  Parts (a) and (c) are reproduced with permission from 
Reviews in Fluorescence 2009; Geddes, CD, Ed.; Springer: New York; pp 345-380.  Parts (b) and 
(d) are reproduced with permission from Biophys. J. 2003. 85, 3294-3302. 
 
1.5.1 Identifying Optimal Experimental Conditions for Measuring Surface 
Binding Thermodynamics and Kinetics using TIR-FCS 
The theoretical model pertaining to ligand-receptor kinetics was extensively 
described by Lieto and Thompson (25).  This work showed that numerous experimental 
(d) 
(c) 
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parameters, including the dimensions of the detection volume, concentration of 
fluorescent ligand and density of surface-bound receptors, affect the magnitude and shape 
of the autocorrelation curve.  As a result, it is difficult to identify experimental conditions 
that will yield TIR-FCS curves that have high signal-to-noise ratios and contain 
significant information about the thermodynamic and kinetic parameters of interest.  To 
address this difficulty, we defined criteria that, if satisfied, would yield autocorrelation 
curves that allow for successful measurement of equilibrium binding constants and rate 
constants.  We then systematically explored the parameter space to identify experimental 
conditions that would satisfy the criteria.  The work is geared to serve as a general guide 
to determine optimal experimental conditions for TIR-FCS measurements involving 
different biological systems and thereby ease the implementation of the technique.  This 
work was outlined in a paper I co-authored (31) and is included in Chapter 2 of this 
dissertation. 
1.5.2 Establishing Biological Systems to Test TIR-FCS Theory Pertaining to 
Nonfluorescent Molecules 
Previous theoretical work had indicated that TIR-FCS can also be used to measure 
the thermodynamic and kinetic properties of nonfluorescent molecules that reversibly 
associate with surface binding sites and thereby interfere with the binding of a fluorescent 
species (25, 30).  These nonfluorescent molecules may either compete with the 
fluorescent reporter to bind surface binding sites (25), or bind the receptor and 
allosterically enhance or reduce the affinity of the receptor for the fluorescent ligand 
(Thompson et al., unpublished).  As a first step towards determining whether TIR-FCS 
yields the thermodynamic and kinetic parameters of nonfluorescent molecules in practice, 
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I set out to implement two biological test systems, one containing a nonfluorescent 
enhancer and the other, a nonfluorescent competitor. 
1.5.2.1 Rifampicin – independent interactions between the pregnane X 
receptor ligand binding domain and peptide fragments of co-
activator and co-repressor proteins 
For a test system containing a nonfluorescent enhancer, we chose a nuclear 
receptor, the pregnane X receptor (PXR), one of its co-activator proteins and an 
established ligand of PXR, rifampicin.  PXR regulates the expression of drug 
metabolizing enzymes in a ligand-dependent manner (32).  The existing model of nuclear 
receptor action states that upon binding agonists, nuclear receptors associate with co-
activators, which in turn recruit downstream members of the cell’s transcription 
machinery.  We thought to adopt a system in which the PXR agonist rifampicin would 
serve as a nonfluorescent enhancer and a fluorescently labeled peptide derived from the 
steroid receptor co-activator 1 (SRC-1) would serve as the fluorescent reporter.  The PXR 
ligand binding domain (PXR-LBD) was in turn immobilized on fused silica microscope 
slides via a biotin – avidin linkage.  As the interaction among PXR, its co-regulator 
proteins and agonists had not been biophysically characterized prior to this work, we used 
established techniques, TIRFM and TIRFM combined with fluorescence recovery after 
photobleaching (TIR-FRAP), to measure the thermodynamics and kinetics of the 
interaction between PXR-LBD and SRC-1 in the presence and absence of rifampicin.  
Contrary to expectations, rifampicin did not alter the affinity of PXR-LBD for SRC-1.  
Although the system could not be used to test TIR-FCS theory pertaining to 
nonfluroescent enhancers, the work strongly suggested that the mechanism of PXR action 
differed from that of other nuclear receptors.  These findings were published in 
Biochemistry (33) and are included in Chapter 3 of this dissertation. 
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 As agonists are also thought to decrease the affinity of nuclear receptors for co-
repressors (34-36), we used TIRFM to investigate the interaction between PXR-LBD and 
peptides derived from co-repressor proteins.  Again, rifampicin did not alter the affinity 
of PXR-LBD for its co-repressors.  However, as co-activator and co-repressor binding 
sites on nuclear receptors overlap significantly (37), co-activator and co-repressor 
peptides compete with each other to bind PXR-LBD.  We thereby had a system with 
which to test the nonfluorescent competitor theory.  In addition, PXR-LBD and its 
interacting partners could be used to test the experimental conditions (Chapter 2) that 
were predicted to yield informative autocorrelation curves with good signal-to-noise 
ratios. 
1.5.2.2 Fc Receptor and IgG Interactions: A Test System for TIR-FCS 
 To test the nonfluorescent competitor theory, we initially sought to use an IgG 
and its Fc receptor, FcγRII.  Unlike PXR interactions, the interaction between antibodies 
and their Fc receptors are well characterized (14).  However, a known competitive 
inhibitor of IgG/FcγRII binding did not exist.  We designed a system in which an IgG, 
1B7.11, was immobilized on supported planar membranes via its antigen binding site.  
The soluble, extracellular portion of FcγRII (sFcγRII) was fluorescently labeled and 
introduced into the aqueous medium between the microscope slide and cover slip.  To 
obtain nonfluorescent competitors, we synthesized peptides fashioned from the antibody 
binding site on FcγRII (38, 39).  One of these peptides was able to compete with sFcγRII 
to bind surface-bound IgG.  However, this peptide was not sufficiently soluble in aqueous 
media.  If this system is to be used for purposes of testing the theory, the solubility of the 
peptide would have to be improved.  The above work is described in Chapter 4 of this 
dissertation. 
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1.6 Summary 
 The motivation for the work described herein was the development and extension 
of TIR-FCS to the study of ligand-receptor kinetics.  We systematically examined TIR-
FCS theory pertaining to ligand-receptor interactions to identify experimental conditions 
that were most likely to yield autocorrelation curves containing significant information 
about the thermodynamic and kinetic parameters of interest.  Subsequent work showed 
that PXR and antibody/Fc receptor systems could be used to test the predicted 
experimental conditions.  To determine whether TIR-FCS yielded information about 
nonfluorescent molecules that alter the binding of fluorescent ligands to surface binding 
sites, we established a system in which peptides derived from co-regulator and co-
activator proteins compete with each other to bind surface-bound PXR.  In establishing 
this system, we determined that the PXR agonist, rifampicin, does not alter the affinity of 
the receptor for peptides derived from co-regulator proteins.  These findings have 
significant implications for the existing model of PXR action, and are of interest to the 
nuclear receptor community.  In future work, we would use the biological systems 
established herein to test the theoretical predictions and explore the limits of TIR-FCS 
with regards its application to the study of ligand-receptor interactions. 
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Chapter 2 
 
Identifying Optimal Experimental Conditions for Measuring Surface 
Binding Thermodynamics and Kinetics using TIR-FCS 
 
2.1 Overview 
 The combination of total internal reflection illumination and fluorescence 
correlation spectroscopy (TIR-FCS) is an emerging method useful for, among a number 
of things, measuring the thermodynamic and kinetic parameters describing the reversible 
association of fluorescently labeled ligands in solution with immobilized, nonfluorescent 
surface binding sites.  However, there are many parameters (both instrumental and 
intrinsic to the interaction of interest) that determine the nature of the acquired 
fluorescence fluctuation autocorrelation functions.  In this work, we define criteria 
necessary for successful measurements, and then systematically explore the parameter 
space to define conditions that meet the criteria.  The work is intended to serve as a guide 
for experimental design; in other words, to provide a methodology to identify 
experimental conditions that will yield reliable values of the thermodynamic and kinetic 
parameters for a given interaction. 
 
 
Chapter 2 reproduced with permission from: Thompson, N. L., Navaratnarajah, P., Wang, X. 
(2011) Journal of Physical Chemistry B, 115, 120-131. Copyright 2011 American Chemical 
Society. 
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2.2 Introduction 
Interactions between soluble ligands and membrane-bound species are an integral 
part of many, if not most, cellular processes.  Many disease-causing microorganisms bind 
cell-surface molecules as a first step in pathogenesis and the subsequent immune 
response.  A majority of pharmaceutical products target cell-surface receptors.  
Intercellular communication is often facilitated by soluble factors circulating between 
cells.  Numerous intracellular mechanisms involve the interaction of soluble factors with 
the membranes of sub-cellular organelles, with the factors being present either in the 
cytosol or within the organelle.  Consequently, to fully understand pathogenic processes, 
determine the mechanism of action of drugs, and characterize both intercellular and 
intracellular biological processes, the thermodynamic and kinetic parameters of relevant 
ligand-receptor interactions must be known.  Total internal reflection with fluorescence 
correlation spectroscopy (TIR-FCS) is an emerging technique that allows one to study the 
reversible interaction between soluble and surface-associated species (1-5). 
TIR-FCS combines two established techniques: total internal reflection 
fluorescence microscopy (TIRFM) and fluorescence correlation spectroscopy (FCS).  In 
TIRFM, a laser beam approaching an interface between two media with different 
refractive indices, from the higher refractive index side and at an angle greater than the 
critical angle, is internally reflected.  Total internal reflection gives rise to a thin, surface-
associated light layer called the evanescent wave.  This wave penetrates into the lower 
refractive index medium, and decays approximately exponentially with increasing 
distance from the interface. Evanescent illumination can therefore be used to achieve 
surface specificity and limit the size of the detection volume.  In TIR-FCS, a pinhole or 
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fiber optic, placed at a back image plane, is employed to further reduce this volume.  A 
small detection volume ensures that a small number of fluorescent molecules are 
observed at a given time, not a large number that would only yield small fluorescence 
fluctuations.  The fluorescence fluctuations arising from number fluctuations are auto-
correlated.  The magnitude of the fluorescence fluctuation autocorrelation function is 
inversely related to the average number of fluorescent molecules in the detection volume.  
The rate and shape of decay of the autocorrelation function contain information about the 
processes giving rise to the observed fluorescence fluctuations, such as diffusion through 
the evanescent wave or reversible association with the surface.  To obtain values of the 
parameters describing these processes from TIR-FCS autocorrelation functions, 
knowledge of the appropriate theoretical form for a given optical arrangement and 
molecular process is required. 
 TIR-FCS has thus far been used primarily to investigate the mobility of small 
fluorescent molecules close to surfaces (6-12).  TIR-FCS has also been used to 
characterize the diffusion coefficients of fluorescently labeled proteins (13, 14) and 
particles (15) close to supported phospholipid membranes; molecular transport in sol-gel 
films (16-18), and the mobility of intracellular vesicles very close to the basal membranes 
of live, adherent cells (19, 20).  In addition, TIR-FCS has been used to study the 
reversible interaction of fluorescent species with surfaces; i.e., fluorescently labeled IgG 
and insulin with albumin-coated surfaces (21), rhodamine 6G with C18-coated silica (22-
23), fluorescently labeled bovine serum albumin and Thermomyces lanuginosus lipase 
with C18-coated glass in the presence of surfactants (24), and fluorescently labeled IgG 
with Fc receptors reconstituted in supported planar membranes (25).  Applications to 
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enzyme kinetics (26), triplet state photo-physics (27, 28), and the association of cytosolic 
molecules with the basal membranes of live, adherent cells (7, 29, 30) have also been 
reported. 
 The use of TIR-FCS to examine the thermodynamic and kinetic parameters of 
soluble, fluorescent ligands reversibly associating with non-fluorescent surface binding 
sites is a promising method because it requires very small amounts of material.  First, the 
fluorescence fluctuation autocorrelation functions obtained from FCS, in general, are 
roughly inversely proportional to the average number of fluorescent molecules within the 
observed volume.  Therefore, TIR-FCS has the advantage of requiring low concentrations 
of fluorescent ligands.  Second, because the non-fluorescent binding sites are present in a 
monomolecular layer on a surface, only small amounts of these molecules are also 
required.  Another advantage of TIR-FCS is related to its recent combination with high-
speed imaging detectors (30-33).  This arrangement, coupled with microfluidic devices, 
promises high throughput acquisition of numerous fluorescence fluctuation 
autocorrelation functions (e.g., as a function of the fluorescent ligand concentration and 
surface site density) from a single time-sequence of images and therefore rapid dissection 
of surface binding mechanisms. 
 TIR-FCS autocorrelation functions are predicted to depend on many different 
parameters; so many that it is difficult to readily identify experimental conditions that 
will yield autocorrelation curves that contain significant information about the 
thermodynamic and kinetic parameters which describe the interaction of fluorescent 
ligands with non-fluorescent surface binding sites.  Therefore, in this work, we evaluate 
the parameter space in a systematic manner to identify viable experimental conditions.  
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First, a set of criteria necessary for the autocorrelation curves to contain the desired 
information with high signal-to-noise ratios are defined.  Then the previously derived 
theoretical form of the autocorrelation function is used to determine the experimental 
conditions that meet these criteria.  The results are somewhat surprising in the inferred 
limitations on experimental parameters (primarily, upper limits on the allowed 
concentrations of fluorescent ligands given a defined equilibrium association constant).  
While many conditions are predicted not to yield viable TIR-FCS data, a number of 
conditions that are likely to yield productive data are identified.  Thus, the results 
presented in this paper serve as a comprehensive guide to the design of TIR-FCS 
measurements aimed at measuring the kinetic and thermodynamic parameters describing 
the association of fluorescent ligands with non-fluorescent surface binding sites.  Also, 
the work described here serves as a prerequisite for the design of measurements aimed at 
using a single, well characterized fluorescent reporter to scan non-fluorescent, soluble 
competitors for the thermodynamic and kinetic properties describing reversible 
association with the non-fluorescent surface binding sites (34, 35).  Similarly, a single 
fluorescent reporter might be used to characterize non-fluorescent effectors that non-
competitively interact with binding sites and enhance or reduce fluorescent reporter 
binding. 
2.3 Theoretical Background 
2.3.1 Total Internal Reflection with Fluorescence Correlation Spectroscopy 
Figure 2.1 illustrates the conceptual basis of TIR-FCS.  Measurements are carried 
out on an inverted optical microscope.  The sample plane, containing surface-binding 
sites for soluble fluorescent ligands, is the interface between optically transparent high 
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and low refractive index materials (usually fused silica or glass and a buffered aqueous 
solution, respectively) and is placed at the focal plane of the microscope.  Positions 
within the sample plane are described by polar coordinates (r, φ) and the distance from 
the sample plane into the lower refractive index medium is defined by coordinate z ≥ 0.  
An excitation source is internally reflected at the sample plane, creating a thin, surface-
associated evanescent wave in the lower refractive index medium.   Internal reflection 
may be generated by using either a through-prism or through-objective mechanism.  The 
evanescent excitation intensity is assumed to decay exponentially with position z and 
characteristic distance d (usually ≈ 0.1 μm).  Worth noting is that this assumption may 
not be completely accurate, as previously reviewed (1), but that deviations from 
exponential behavior, if they occur, are expected to be minimal.  The observed volume is 
further defined by a pinhole or fiber optic placed at a back image plane of the 
microscope.  It is assumed that the observation area in the sample plane, as defined by the 
back image plane detection restriction, is circular with radius h ≈ 0.5 μm and area ≈ πh2.  
Furthermore, the spatial extent of the evanescent intensity within the sample plane is 
assumed to be large enough so that the evanescent intensity within the observation 
volume does not depend on r.  At chemical and thermal equilibrium, individual 
fluorescent molecules diffuse in solution within the observation volume, and also bind to 
and dissociate from surface binding sites.  The fluorescence arising from the observation 
volume, defined by the evanescent excitation and projected area of the back image plane 
aperture on the sample plane, is collected through a high numerical aperture objective, 
detected by a sensitive photomultipler or silicon avalanche diode, and is denoted as F(t).  
Because only a small number of fluorescent molecules are within the observed volume, 
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the fluorescence fluctuates significantly with time.  The fluorescence fluctuations, δF(t) = 
F(t) - <F>, where the brackets denote equilibrium (i.e., time-averaged or ensemble-
averaged) values, are auto-correlated.  The normalized, dimensionless autocorrelation 
function is defined as 
2
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and contains information about diffusion through the evanescent wave in addition to 
surface binding kinetics. 
 
Figure 2.1:  TIR-FCS.  A laser beam is totally internally reflected at a planar interface between 
media with two different refractive indices, creating an evanescent field that penetrates a depth d 
into the lower refractive index medium.  A small sample volume is defined by this depth in 
combination with a circular aperture or fiber optic placed at an intermediate image plane of the 
microscope that defines an area of radius h in the sample plane.  The fluorescence measured from 
the small sample volume adjacent to the surface fluctuates with time as individual fluorescent 
ligands diffuse into the volume, bind to surface-associated receptors, dissociate, and diffuse out of 
the volume.  These fluorescence fluctuations are autocorrelated and fit to theoretical expressions 
to obtain information about the dynamics at or near the surface. 
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2.3.2 Reaction Mechanism 
Consider a situation in which a single fluorescent species in solution interacts 
with binding sites on a surface through a simple, reversible bimolecular reaction (Figure 
2.2).  Fluorescent molecules in solution with average concentration A are in equilibrium 
with unoccupied, nonfluorescent surface binding sites of average density B, forming an 
average density of fluorescent, surface-bound complexes, C.  The surface association and 
dissociation rate constants are denoted by ka and kd, respectively.  The mechanism can be 
written as  
d
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          (2.2) 
where the equilibrium association constant describing the reaction is  
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The total surface site density is denoted by S. Thus,  
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The total number of surface binding sites within the observed area is defined as N.  In this 
case, 
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where NB is the average number of unoccupied binding sites in the observed area and NC 
is the average number of surface-bound fluorescent molecules in the observed area. 
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Figure 2.2:  Reaction Mechanism.  Fluorescent molecules in solution, A, reversibly bind to non-
fluorescent surface sites, B, forming fluorescent complexes, C.  The association and dissociation 
rates constants are ka and kd, respectively.  The solution diffusion coefficient is D.  The surface 
binding sites and surface-bound complexes are not laterally mobile. 
 
2.3.3 Fluorescence Fluctuation Autocorrelation Function 
A general expression for G(τ) which accounts for fluorescence fluctuations 
arising from diffusion through the evanescent field and from surface association and 
dissociation has previously been published (36).  In this work, it is assumed that the 
surface binding sites and surface-associated complexes are not laterally mobile along the 
surface.  Furthermore, it is assumed that the excitation intensity is low enough so that 
photo-physical processes do not contribute significantly to G(τ). The first assumption can 
be proven by using fluorescence recovery after photobleaching and the second can be 
shown by acquiring data as a function of the excitation intensity.  The published general 
expression is rather complex (36).  In the work described here, we consider the more 
simple form for G(τ) which is applicable when (1) the rates for diffusion in solution 
through the observation volume are much faster than the rates associated with surface 
association and dissociation and (2) rebinding of previously dissociated fluorescent 
molecules within the small observed area is negligible.  In this case, 
)()()(  as GGG          (2.6) 
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where the first term describes contributions to the autocorrelation function from surface 
binding kinetics and the second term describes contributions from diffusion of 
fluorescent molecules in solution but within the evanescent wave. 
2.3.4 Magnitude of the Fluorescence Fluctuation Autocorrelation Function 
Because the observation volume is open with respect to coordinate z, fluctuations 
in the concentration of fluorescent molecules in solution obey Poisson statistics.  
However, because there is a finite number of surface binding sites in the observed area, 
fluctuations in the densities of surface-bound species obey binomial rather than Poisson 
statistics.  These statements lead to the conclusion that (36) 
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where the average number of unbound fluorescent molecules in the observed volume is 
dAhNA
2           (2.8) 
It is convenient to define a dimensionless quantity proportional to the solution 
concentration, X = KA.  In this case, Eqs. 2.7 can be rewritten as 
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2.3.5 Time-Dependence of Ga(τ) 
As shown previously (9, 36), 
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where D is the diffusion coefficient of the fluorescent molecules in solution,  Rz is the 
rate associated with diffusion in solution perpendicular to the surface and through the 
depth of the evanescent wave, and Rr is the rate associated with diffusion in solution 
parallel to the surface and through the extent of the observed area.  Both factors in the 
first expression in Eq. 2.10 equal one when τ = 0 and monotonically decay to zero as τ → 
∞.  For a protein with a molecular weight of ≈ 100 kD, D ≈ 50 μm2sec-1.  Typically, d ≈ 
0.1 μm, and h ≈ 0.5 μm, so that, for this value of D, Rz ≈ (0.2 ms)
-1
 and Rr ≈ (1.25 ms)
-1
.  
The minimum decay rate of Ga(τ) is Rz; Rr only speeds the decay.
1
 
2.3.6 Time-Dependence of Gs(τ) 
Given the assumptions that the rates for diffusion in solution through the 
observation volume are much faster than the rates associated with surface association and 
dissociation and that rebinding of previously dissociated fluorescent molecules within the 
small observed area is negligible, Gs(τ) has the form of an exponential decay (36, 37): 
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     (2.11) 
The first expression decays from one to zero with time. 
2.4 Results 
2.4.1 Measurement of K by Steady-State TIRFM 
Independent of TIR-FCS, the simplest method for measuring the value of the 
equilibrium association constant is by using steady-state TIRFM (38-42).  In this 
approach, the evanescently excited fluorescence is measured as a function of the 
concentration of fluorescent molecules in solution.  The data are of the form 
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where Fpos(A) is the fluorescence measured for surfaces containing binding sites, the first 
term in Fpos(A) arises from fluorescent ligands bound to surface sites, the second term in 
Fpos(A) arises from fluorescent molecules in solution but close enough to the surface to be 
excited by the evanescent wave, Fneg(A) is the fluorescence measured for surfaces not 
containing binding sites, and Q is a proportionality constant. 
 The difference between the fluorescence measured in the presence (S > 0) and 
absence (S = 0) of surface binding sites has the shape of a standard binding isotherm 
which can be curve-fit as a function of A to find the best value of K (and QS).  The 
primary limitation of this type of measurement is that the surface site density in the 
positive samples must be high enough so that the first term in Eq. 2.12 is not 
overwhelmed by the second term.  This feature is illustrated in Figure 2.3.  As shown, 
higher binding site densities are required for lower values of K.  If a general rule is set 
that the fluorescence measured in the presence of binding sites must be at least twice that 
measured in the absence of binding sites when A = K
-1, then one finds that S ≥ 2d/K.  
Thus, when d = 0.1 μm, the approximate lower limit for S ranges from 12,000 
molecules/μm2 for K = 104M-1 to 12 molecules/μm2 for K = 107M-1.  In addition, for 
adequate curve-fitting, because the value of QS and therefore the saturation point is 
usually unknown, data must be acquired for solution concentrations up to at least 
(approximately) 4/K, where the surface binding sites are 80% occupied. 
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Figure 2.3:  Measurement of K by Steady-State TIRFM.  These plots show the values of Eq. 
2.12 for d = 0.1 μm and K equal to (a) 105M-1, (b) 106M-1 or (c) 107M-1.  The surface site densities 
S in units of molecules/μm2 are (red) 3000, (blue) 1000, (green) 300, (pink) 100 or (black) zero. 
The difference between the values shown in (a-c) with S > 0 and with S = 0 have the same shape 
when plotted as a function of the product of K and A and are shown in panel (d). 
 
2.4.2 Criteria for TIR-FCS 
As shown in the previous section, G(τ) is predicted to depend on a rather large 
number of parameters, some of which are experimentally adjustable and some of which 
will be intrinsic to a given system of interest.  Because so many parameters are present in 
the expression specifying the autocorrelation function and because all measured G(τ) will 
contain experimental uncertainties, identifying combinations of the parameter values 
which can be reasonably predicted to allow characterization of the mechanism shown in 
Figure 2.2 is not straightforward.  Referring to Eqs. 2.6 and 2.9-2.11, one finds that the 
expression for G(τ) depends on seven independent parameters:  K, kd, X, d, h, D and S 
(Table 2.1).  To make analysis tractable, we have set the values of d (0.1 μm), h (0.5 μm), 
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and D (50 μm2s-1), leaving four free parameters rather than seven.  In addition, in many 
cases we have assumed that ka = 10
6
 M
-1
s
-1
 as is common for processes at surfaces, thus 
fixing the value of kd given a value for K, leaving three free parameters:  K, X, and S. 
Although these selections may not apply to a given system being considered for 
investigation, the procedure we outline below is readily amenable to generalization. 
Table 2.1:  Parameters Governing the Behavior of G(τ) 
Parameter Description
A average concentration of fluorescent molecules in solution
K (*) equilibrium association constant for fluorescent molecules and surface binding sites
X (*) product of K and A
ka (***) kinetic association rate constant for fluorescent molecules and surface binding sites
kd kinetic dissociation rate for fluorescent molecules and surface binding sites
S (*) total surface site density
d (**) evanescent wave depth
h (**) radius of observed area
D (**) solution diffusion coefficient of fluorescent molecules
Rz rate for diffusion in solution of fluorescent molecules through the evanescent wave
Rr rate for diffusion in solution of fluorescent molecules through the observed area  
 
There are three free (*), three fixed (**) and one partially fixed (***) parameters.  The other four 
quantities depend on different subsets of these parameters as described in the text. 
 
 This work addresses combinations of the values of the three free parameters 
which will reasonably allow measurement by TIR-FCS of properties describing the 
thermodynamic and kinetic behavior of the mechanism shown in Figure 2.2.  The criteria 
that we use are defined in Table 2.2:  (A) G(τ) decays with reasonable rapidity so that 
data can be acquired in a reasonable amount of time.  (B) Diffusion through the 
evanescent wave is fast enough so that Eqs. 2.6 and 2.11 are applicable (36); worth 
noting is that Rr only increases the decay rate of Ga(τ) over that determined by Rz.
1
  (C) 
Gs(0) is high enough so that Gs(τ) is measurable with high accuracy.  Although 
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fluorescence fluctuation autocorrelation functions with magnitudes much lower than the 
minimum given in Table 2.2 are often measurable, in all but the simplest case (Eq. 2.11), 
Gs(τ) is not a single exponential (35) and higher values of Gs(0) are required to resolve, 
for example, the rates and relative amplitudes associated with two exponentials.  (D) The 
magnitude of Gs(τ) is high enough so that G(τ) is not dominated by Ga(τ).  (E) Significant 
rebinding to the surface within the observed area does not occur so that Eqs. 2.6 and 2.11 
are applicable. 
Table 2.2:  Criteria 
 
Criterion Description Quantification 
A fluorescence fluctuations must be fast enough λ ≥ 0.1 s-1  
B diffusion through the evanescent wave must be fast enough λ ≤ 500 s-1 
C magnitude of Gs(τ) is high enough Gs(0) ≥ 0.05  
D Gs(τ) is not overwhelmed by Ga(τ) Gs(0)/Ga(0) ≥ 0.1  
E surface rebinding is negligible P ≤ 0.05 
 
This table describes the criteria used to determine conditions for which TIR-FCS can measure 
thermodynamic and kinetic parameters describing the interaction of fluorescent molecules with 
surface binding sites given that the mechanism is a simple bimolecular reaction as defined in Eq. 
2.2. 
 
2.4.3 Experimental Conditions that Meet the Criteria 
Criterion A requires that the fluorescence fluctuations be fast enough for G(τ) to 
be measurable with a good signal-to-noise ratio.  We have quantified this criterion by 
specifying that Gs(τ) decays with a rate ≥ 0.1 s
-1
.  Referring to Eq. 2.11, one sees that the 
decay rate for Gs(τ) will always be ≥ kd.  Thus, assuming that ka = 10
6
 M
-1
s
-1
 (see above), 
K ≤ 107 M-1 (Eq. 2.3). 
 Criterion B requires that the decay rate of Gs(τ) be at least ten times slower than 
Rz (5000 s
-1
).  To determine ka, it would be far above sufficient to obtain G(τ) for values 
of kaA = 4kd (λ = 5kd in Eq. 2.11).  In this case, the decay rate of Gs(τ) for K = 10
7
 M
-1
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would range from 0.1 to 0.5 s
-1
, meeting criterion B. The minimum value of 5kd is 500 s
-
1
, implying that (with ka = 10
6
 M
-1
s
-1) K ≥ 104 M-1. 
 Criteron C requires that Gs(0) ≥ 0.05.  Although this condition might seem to be 
too restrictive, it has been adopted primarily because we are ultimately interested in Gs(τ) 
that are more complex than Eq. 2.11 (see above).  Gs(0) depends on three independent 
parameters (K, S and X) (Eq. 2.9), not including those that have been set at fixed values 
(h and d).  Table 2.3 shows the conditions which conform to criterion C for different 
values of K, S and X.  Worth noting first is that the partial derivative of Gs(0) with 
respect to X is negative, indicating that Gs(0) increases with decreasing X for set values 
of S and K.  Second, the partial derivative of Gs(0) with respect to K is positive, 
indicating that Gs(0) increases with increasing K for set values of S and X.  Third, the 
situation is a bit more complex when one considers the dependence of Gs(0) on S.  In this 
case, each value of K and X has a value of S for which Gs(0) is maximized, found from 
the partial derivative of Gs(0) with respect to S.  These values of S, denoted by Smax, are 
K
Xd
S
)1(
max

          (2.13) 
and are shown in Table 2.3.  By using Eq. 2.13 in Eq. 2.9, one finds that, when S = Smax,  
)1(4
)]0([
2max XdXh
K
Gs



        (2.14) 
These values are shown as upper limits in Table 2.3.  Eq. 2.14 implies a maximum value 
of X, which is found by setting this expression equal to 0.05 and solving for X.  The 
result is 
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The values of Xmax are given as upper limits in Table 2.3.  Fourth, there are two values of 
S for which Gs(0) = 0.05 (criterion C), denoted as S1,2, which bracket the acceptable 
range of surface site densities.  These values, found by setting Gs(0) in Eq. 2.9 equal to 
0.05, are  
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S1 and S2 are real for X ≤ Xmax.  When X=Xmax, the square root in Eq. 2.16 is zero and 
S1=S2=Smax.  In some cases, the minimum value of S, S1, is < 1 molecule/μm
2
.  Because h 
= 0.5 μm, the approximate size of the observed area is πh2 = 0.8 μm2 so that, for these 
low values of S, some observed areas will contain no binding sites.  In other cases, the 
maximum value of S, S2, is very high and may not be experimentally achievable.  
However, criterion E reduces these maximum values to experimentally reasonable ones 
(see below).  The values of Gs(0) as a function of X, for different values of K and S = 
Smax are plotted in Figure 2.4a.  As shown, in many cases Gs(0) >> 0.05. 
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 Criteron D requires that the ratio of Gs(0) and Ga(0) be ≥ 0.1, so that the long-time 
tail of Ga(τ) does not overlap too much with Gs(τ).  This ratio (see Eqs. 2.9) is 
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and, as shown, increases with K and S; and decreases with X and d.  However, when S = 
Smax, Gs(0)/Ga(0) = 2/(1 + X) and depends only on X (Figure 2.4b).  In this case, because 
X is always less than or approximately equal to 0.64 (Table 2.3), the ratio ranges from ≈ 
2 at low X to 1.2, well above 0.1.  In general, for a given value of K and X, an initial 
maximum value of Gs(0)/Ga(0) can be found with S = S2.  As shown in Figure 2.4b, these 
maximum values of the ratio are all much greater than 0.1, so that in these cases criterion 
D is always satisfied.  However, for a given value of K and X, the minimum value of the 
surface site density, according to criterion C, is for S = S1, and as shown in Figure 2.4b, 
the ratios Gs(0)/Ga(0) for S1 are not all greater than the allowed value of 0.1.  This result 
sets a new minimum for the site density, denoted by S3, which is determined by setting 
the expression for the ratio in Eq. 2.17 equal to 0.1 and solving for the value of S.  The 
values of S3 are  
K
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S
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The actual minimum site densities are thus equal to the maxima of S1 and S3 and are 
shown as the lower limits in the S ranges in Table 2.3. 
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Figure 2.4:  Conditions Required for TIR-FCS.  In all panels, the colors denote (red) K = 10
7 
M
-1
; (blue) K = 3 x 10
6 
M
-1
; (green) K = 10
6 
M
-1
; (pink) K = 3 x 10
5 
M
-1
;
 
(cyan) K = 10
5 
M
-1
; (dark 
red) K = 3 x 10
4 
M
-1
; and (dark green) K = 10
4 
M
-1
.  Panel (a) shows the values of [Gs(0)]max 
calculated from Eq. 2.14 and as a function of X.  In these plots, S = Smax (Eq. 2.13 and Table 2.3).  
The black line depicts the cutoff values of X for which Gs(0) ≤ 0.05 and criterion C is not 
satisfied.  Panel (b) shows the values of Gs(0)/Ga(0) calculated from Eq. 2.17 and as a function of 
X.  Solid, colored lines are for S = S2 and dashed, colored lines are for S = S1. The solid black line 
is for S = Smax and does not depend on K.  The dashed black line shows the cutoff value below 
which the ratio is unacceptable according to criterion D.  Panel (c) shows P calculated by 
numerically integrating Eq. 2.19 with Eq. 2.20.  The value of ka is taken to equal 10
6 
M
-1
s
-1
 and 
the values of S are (solid) S2; (dash) Smax; and (dash-dot) the maximum of S1 and S3.  The black 
line depicts the cut-off value for which P ≥ 0.05 and criterion E is not satisfied. 
 
 Criterion E requires that rebinding to the surface after dissociation, within the 
observed area, is negligible.  The purpose of this requirement is to ensure that Eqs. 2.6 
and 2.11 are applicable, as their derivation depends on the assumption that the rates 
associated with rebinding are much lower than the intrinsic rates associated with the 
mechanism shown in Eq. 2.2 (36).  As shown previously (43, 44), the probability that a 
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molecule which dissociates from the origin at time zero has rebound at least once 
between positions r = 0 and r = h, and at time infinity, is 
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In Eqs. 2.19, the parameter η describes the propensity for surface rebinding and is defined 
as 
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Rebinding is more likely when the surface site density is higher, when the surface 
binding sites are less occupied, when the association kinetic rate constant is higher, and 
when the diffusion coefficient in solution is small.  When h → ∞, the integral in Eq. 2.19 
is (45) 
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A molecule which dissociates from an infinite plane always eventually rebinds 
somewhere on the surface.  However, in the work described in this paper, h is small and 
the values of P are also (usually) small.  Values of P as a function of X, with ka = 10
6
 M
-
1
s
-1
 and S = S2, Smax, or the maximum of S1 and S3, were calculated by numerically 
integrating the second expression in Eq. 2.19 with Eq. 2.20.  As shown in Figure 2.4c, P 
is usually much less than the cutoff value of 0.05.  Exceptions are found for higher values 
of S, and lower values of X and K.  For a given X value, an upper limit for S, denoted by 
S4, can be found numerically for P = 0.05.  These values range from 3300 – 5400 
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molecules/μm2.  The true maximum site densities are equal to the minima of S2 and S4 
and are shown as upper limits in the S ranges in Table 2.3.  [For the lowest K, Smax is 
greater than the upper limit and, when X=Xmax (0.00106), the upper limit is less than the 
lower limit, and therefore no values of S meet all five criteria.  These results set a new 
upper limit for X (9.65x10
-4
).] 
2.4.4 Measurement of K by TIR-FCS 
A first question, given that criteria A-E are satisfied, is how one might go about 
measuring the equilibrium association constant K by using TIR-FCS rather than steady-
state TIRFM.  This type of measurement might be useful for a number of situations.  One 
class of such situations includes in vivo cases in which the parameters cannot be precisely 
controlled or known (e.g., when one is interested in examining reversible association of 
fluorescent molecules in the cytosol with sites on the cytoplasmic face of adherent cells 
illuminated by evanescent excitation).  Another class includes those in which one finds it 
not to be possible to make steady-state in vitro TIRFM measurements up to A ≈ 4/K (see 
above) because the required higher concentrations of fluorescent ligands with good purity 
are not obtainable within a reasonable amount of time and expense, or precipitate and/or 
oligomerize at high concentrations.  Thus, we define below two methods in which K 
might be measured by using TIR-FCS. 
 First, it should be noted that measures of Fpos(A) and Fneg(A) (Eq. 2.12) will be a 
natural consequence of acquiring TIR-FCS data.  No extraneous steady-state TIRFM data 
acquisition is required.  Then, from the two measured quantities, one can calculate  
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where the dimensionless parameter ρ is 
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           (2.23) 
The wide range of ρ values (0.05 to 550) for different values of K and X are shown in 
Table 2.3.  Curve-fitting the measured values of Eq. 2.22 to the form on the right side, as 
a function of A, will give a best-fit value for ρ and, if high enough A values are 
accessible, also for K.  If one chooses to assume an approximate value for d (1), then an 
approximate value for S can be found from ρ, K and d.  Predicted data are illustrated in 
Figure 2.5a.  As shown, this strategy for measuring K is more likely to be successful for 
higher K values.  Because the accessible values of X are capped at very low values for 
smaller K (Table 2.3), in these cases Eq. 2.22 is approximately constant and equal to ρ.  
Thus, low K values are predicted to be measurable by this method only if the values of S 
and d are independently calibrated. 
 
Figure 2.5:  Measurement of K by using TIR-FCS.  In both panels, the colors denote (red) K = 
10
7 
M
-1
, (blue) K = 3 x 10
6 
M
-1
, (green) K = 10
6 
M
-1
, and (pink) K = 3 x 10
5 
M
-1
; surface site 
densities are (red) 1, (blue) 3.33, (green) 10, and (pink) 33.3 molecules/μm2; and ρ = 0.166.  
Panel (a) shows the values of [Fpos(A)-Fneg(A)]/Fneg(A) calculated from Eq. 2.22.  The intercepts 
equal ρ.  The initial slopes equal –ρK; their magnitudes increase with K.  These slopes are 
indicative of the ability of the proposed strategy to measure K.  Panel (b) shows the values of 
[Gneg(0)-Gpos(0)]/[Gneg(0)] calculated from Eq. 2.25.  The intercepts equal [ρ/(1+ρ)]
2
.  The initial 
slopes are 2Kρ/(1+ρ)3 and increase with K. 
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 Because measuring equilibrium association constants by using only values of A 
that are less than K
-1
 is vulnerable to potential artifacts, it is desirable to confirm the 
measured K value by using the information contained in the magnitudes of the acquired 
G(τ).  There are two directly measurable quantities, G(0) in the presence and absence of 
surface binding sites, denoted as Gpos(0) and Gneg(0), respectively.  Referring to Eqs. 2.6 
and 2.9, one finds that 
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To accurately measure these quantities, it may be necessary to account for photophysical 
effects that can occur at high excitation intensities and low time lags τ (27, 28).  This 
correction is necessary only if the excitation intensity is high enough so that the measured 
G(τ) are dependent on it.  In addition, the G(0) values must be extrapolated from G(τ) at 
low τ because when τ = 0 the autocorrelation functions contain contributions from shot 
noise.  In analogy to Eq. 2.22, the following function can be defined: 
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Eq. 2.25 is positive because Gneg(0) > Gpos(0).  This at first counter-intuitive result is 
because, when comparing Gneg(0) to Gpos(0) for a given A value, there are fewer 
fluorescent molecules in the observed volume due to the lack of surface binding sites, and 
fewer fluorescent molecules in general translates into higher magnitudes for fluorescent 
fluctuation autocorrelation functions.  Figure 2.5b shows the expected values of Eq. 2.25 
as a function of K, A and set values of S.  Curve-fitting the measured values of Eq. 2.25 
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to the form on the right side, as a function of A, will return best-fit values of ρ and, if 
high enough values of A are accessible, K. 
2.4.5 Measurement of kd, or kd and ka, by TIR-FCS 
One way to measure kd is by using evanescent illumination with fluorescence 
recovery after photobleaching (37, 38, 40, 46, 47).  However, this method cannot directly 
report the value of ka, which would need to be inferred from a previously measured value 
of K and the measured value of kd (Eq. 2.3).  TIR-FCS does not have this strict feature of 
reporting only kd and not ka; both rate constants are present in the theoretically predicted 
form for G(τ) (Eq. 2.11). 
 The above discussion defines conditions, as illustrated in Figures 2.4a-c and 
summarized in Table 2.3, for which criteria A, B, C, D and E (Table 2.2) are met, given 
assumed values of d, h, D and ka (Table 1.2).  Thus, for the conditions summarized in 
Table 2.3, we conclude that it is reasonable to expect that the rate associated with the 
exponential decay of Gs(τ) (Eq. 2.11) can be measured with sufficient accuracy.  This rate 
equals kd + kaA and ranges from a minimum of kd to infinity as the concentration of 
fluorescent molecules in solution, A, is increased.  Plotting the measured rate vs. A and 
fitting to a line will in general yield an intercept of kd and a slope of ka. 
 The relaxation rate will increase fast enough with A for ka to be directly 
measurable only if higher values of A are accessible.  However, as shown in Table 2.3, it 
is the higher rather than lower values of A = X/K that limit the range of applicability.  
Rewriting the relaxation rate as kd(1+ X) shows that the measurable rate will increase 
only by a percentage determined by X.  In particular, the prediction is that the measured 
relaxation rate will exceed kd only by ≈ 65% for K = 10
7
 M
-1; by ≈ 25% for K = 3 x 106 
41 
 
M
-1
s
-1
; and by less than 10% for K = 10
6
 – 104 M-1.  Thus, for low K values TIR-FCS will 
yield a measure of kd, but not ka.  Subsequently, ka can be inferred from the measured 
values of K and kd (Eq. 2.3) in which K is measured either with steady-state TIRFM, 
TIR-FCS or with another method. 
 For higher values of K, ka will be directly measurable by TIR-FCS.  First, for K = 
10
7
   M
-1
, the relaxation rate is expected to be measurable through a range of kd to 1.6 kd 
and, given the accuracy of current FCS apparatuses, this range will most likely be wide 
enough for a direct measure of ka.  This optimal case is illustrated in Figures 2.6a-c.  
Figure 2.6a shows the predicted values of G(τ) as a function of τ, for four values of X and 
other defined experimental conditions.  What is immediately obvious from this plot is 
that the main effect of increasing the solution concentration of fluorescent molecules is 
that G(0) is dramatically decreased.  Figure 2.6b shows the predicted values of G(τ)/G(0) 
as a function of τ, for the same four values of X and the same other presumed 
experimental conditions.  This plot shows that, when one changes A (and therefore X), 
the primary effect is that the fractional contributions to G(τ) arising from Gs(τ) and Ga(τ) 
change (Eq. 2.17); as expected, the contribution from Gs(τ) relative to that from Ga(τ) 
decreases with increasing X.  This feature is a consequence of two effects (Eq. 2.5 and 
2.7).  As X is increased, both NC/NA and NB/N decrease as (1+X)
-1
.  Figure 2.6c shows 
Gs(τ)/Gs(0) for the four chosen values of X.  As shown, the decay rate increases with 
increasing concentrations of fluorescent reporter molecules.  The case of K = 3 x 10
6
 M
-1
 
is illustrated in Figures 2.6d-f.  The same features are present, except that Gs(τ)/Gs(0) 
changes only slightly with X.  Thus, accurate measurement of ka will be possible only for 
experimental situations in which both K and the signal-to-noise ratio of G(τ) are high. 
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Figure 2.6:  Measurement of kd, or kd and ka, by TIR-FCS.  Panels (a) and (d) show G(τ) 
calculated from Eqs. 2.6 and 2.9-2.11.  Panels (b) and (e) show G(τ)/G(0).  Panels (c) and (f) 
show Gs(τ)/Gs(0).  In all cases, D = 50 μm
2
s
-1, d = 0.1 μm, and h = 0.5 μm. In (a-c), K = 107 M-1, 
kd = 0.1 s
-1, S= 9 molecules/μm2 and X is (red) 0.6, (blue) 0.4, (green) 0.2 or (black) 0.01. In (d-f), 
K = 3 x 10
6
 M
-1
, kd = 0.33 s
-1, S= 24 molecules/μm2 and X is (red) 0.25, (blue) 0.1, or (black) 
0.01. 
 
2.5 Discussion 
2.5.1 Summary of Results 
 Conditions for which TIR-FCS measurements aimed at quantifying the 
thermodynamic and kinetic parameters associated with a simple, reversible association of 
fluorescent ligands with immobilized, non-fluorescent surface binding sites have been 
defined in detail, for assumed values of the solution diffusion coefficient D (50 μm2s-1), 
the evanescent wave depth d (0.1 μm), the radius of the observed area h (0.5 μm) and for 
a (usually) assumed value of the association rate constant ka (10
6
 M
-1
s
-1
) (Table 2.1).  The 
conditions are defined by five criteria as described in Table 2.2.  Only values of the 
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solution concentration of fluorescent molecules A which are greater than or equal to 10
-
4
/K, where K is the equilibrium constant, were considered. 
 Meeting the criteria gave the following results, as shown in Table 2.3 and Figure 
2.4:  1) K is limited to the range 10
4
 – 107 M-1.  2) For a given K, there is a maximum 
allowed value of A.  These maximum values range from 64-100 nM and correspond to 
lower values of the product    X = KA with decreasing K.  For K = 10
7
 M
-1
, the maximum 
value of X is 0.643 and for K = 10
4
 M
-1
, the maximum value of X is 10
-3
.  3) Ranges of 
allowed total surface site densities, S, exist for given values of K and A.  4) Gs(τ), the 
quantity of interest, is maximized at a defined surface site density for given K and X 
values. 
 As illustrated in Figure 2.3, the most straightforward method of measuring K is to 
use steady-state TIRFM.  However, this method is expected to be successful only for 
higher values of K and S.  Measuring the lowest value of K (10
4
 M
-1
) is expected to be 
possible only if a total surface site density ≥ 12,000 molecules/μm2 can be experimentally 
generated.  At the highest limit of K = 10
7
 M
-1
, only very low total surface site densities, 
≥ 12 molecules/μm2, are predicted to be required.  In addition, high A values must be 
experimentally accessible. 
 Two alternative methods for measuring K with TIR-FCS were also described.  
The first method uses the average fluorescence intensities in the presence and absence of 
binding sites, which will be found as a natural consequence of TIR-FCS measurements 
(Figure 2.5a).  The second method uses G(0) values in the presence and absence of 
binding sites (Figure 2.5b).  These methods are most likely to be successful either for 
high K or when S and d are independently calibrated. 
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 It is desirable, in general, to independently measure all three parameters (K, ka, 
and kd) governing the mechanism shown in Eq. 2.2 and Figure 2.2 and to confirm their 
consistency (Eq. 2.3).  However, as described in the text, both ka and kd are expected to 
be measurable only for higher K values (Figure 2.6).  For lower values of K, TIR-FCS 
will yield only a measure of kd.  In these cases, ka can be inferred from measured values 
of K and kd. 
2.5.2 Comparison with Experimental Results 
 Of interest is the comparison of the theoretical predictions described here with 
previously obtained experimental TIR-FCS data.  The earliest attempt at characterizing 
surface binding kinetics by using TIR-FCS was carried out for the nonspecific, reversible 
interaction of fluorescently labeled IgG with albumin-coated surfaces (21).  G(0) values 
were lower than those considered here (about 0.02) but were dominated by contributions 
from surface kinetics in that Gs(0)/Ga(0) was greater than 10.  However, the characteristic 
time for the decay of G(τ) was fast (several ms), and theoretical considerations suggested 
that the autocorrelation functions were dominated by contributions from surface 
rebinding.  Fitting the data to a form that accounted for this probable effect gave kd = (0.4 
ms)
-1
.  This first work demonstrated the feasibility of TIR-FCS and provided a basis for 
future development. 
 In a subsequent work, extrapolated G(0) values from TIR-FCS measurements 
were used to measure equilibrium association constants for rhodamine 6G with C-18 
derivatized fused silica, with the intent of better understanding reversed-phase 
chromatography (22).  Measurements were carried out for a range of water/methanol 
solutions and NaCl concentrations.  The measured K values were very low, ranging from 
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≈ 3 to ≈ 20,000 M-1.  That such weak equilibrium association constants were measured is 
at first seemingly inconsistent with the results shown in Figure 2.5 and described in the 
associated text.  One difference is that the probe concentrations were very low (50 pM – 
1 nM) so that the values of X were much lower than those considered here (Table 2.3).  
Thus, the measured K values were obtained very far from the midpoint of the binding 
isotherm and must be taken as apparent K applicable to very low solution concentrations.  
However, the primary reason that such low K values were measurable (and with good 
accuracy) is not the low probe concentrations.  The reason appears to be that a much 
different method than the ones considered here was used.  The method incorporated 
direct calibration of Q (Eqs. 2.12) and the observation volume.  In addition, the method 
did not use only the normalized fluorescence fluctuation autocorrelation function (Eq. 
2.1) but instead used both the measured numerator extrapolated to τ = 0, <δF2>, and the 
measured average fluorescence, <F>, as independent quantities. 
 In a very elegant companion study, the kinetics of rhodamine 6G reversibly 
associating with C-18 derivatized fused silica were examined (23).  These measurements 
were also carried out for conditions of very low K (≈ 3 to 2000 M-1) and A (50 pM – 1 
nM).  A number of features of this work are noteworthy.  First, G(τ) were analyzed by 
using a more complex expression previously derived (36, 37) which includes 
contributions arising from a rate related to surface rebinding (43, 44), and these 
contributions were not negligible.  Second, in most cases, G(0) was much lower than 
considered in this work (≈ 5 x 10-4 to 5 x 10-3).  Nonetheless, by estimating the rates 
associated with diffusion through the evanescent wave and with rebinding and fixing 
these rates before curve-fitting, values of the relaxation rate kaA + kd were measured.  
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Not surprisingly, because the X values were so low, this rate was dominated by kd, which 
ranged from ≈ 40 to 4000 s-1.  Previously measured values of K were then used to 
calculate ka, which ranged from ≈ 10
4
 to 10
5
 M
-1
s
-1
.  In comparison to the results 
described herein, this work highlights the fact that the criteria defined in Table 2.2 are 
more restrictive than is necessary.  We have adopted the more restrictive criteria because 
of the goal of using a single fluorescent reporter to measure the thermodynamic and/or 
kinetic parameters associated with non-fluorescent species involved in more complex 
surface binding mechanisms (see below). 
 In a somewhat similar set of measurements, the kinetics of fluorescently labeled 
polyamidoamine dendrimers (with different sizes) at fused silica surfaces were 
characterized by using TIR-FCS (16).  Equilibrium constants were found from G(0) 
values along with other calibrations, and ranged from 5 x 10
4
 to 2 x 10
6
 M
-1
.  The 
solution concentrations were very low, corresponding to much lower values of X than 
those considered here; the G(0) values were very low; and the surface site densities were 
also higher than the maximum values shown in Table 2.3.  The low X values are 
predicted to preclude direct measurement of ka, and this prediction was in fact observed.  
The high surface site densities should in theory result in significant rebinding, removing 
the ability of TIR-FCS to measure kd.  However, significant flow was included in this 
work, removing complications from rebinding, and values of kd ranging from 6 to 70 s
-1
 
were measured.  Association rate constants ka were inferred from the measured values of 
K and kd and ranged from 3 x 10
6
 to 10
7
 M
-1
s
-1
.  Overall, the experimental results 
described in this work are consistent with our theoretical predictions.  The results also 
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provide a direct demonstration that flow can remove constraints arising from rebinding 
and that it is possible to work at very low G(0) values given adequate instrumentation. 
 The first use of TIR-FCS to examine the kinetics of the reversible association of 
fluorescent ligands with specific, molecular surface binding sites was carried out for 
fluorescently labeled IgG reversibly associating with the mouse Fc receptor FcγRII 
reconstituted into planar phospholipid bilayers formed on fused silica surfaces (25).  
There is a difficulty in comparing the results with those described herein because a tracer 
amount of labeled IgG was combined with a large excess of unlabelled IgG so that the 
total ligand concentration was close to the mid-point of the binding isotherm.  The effects 
of the presence of the non-fluorescent competitors on TIR-FCS data have been formally 
defined (35) but have not yet been fully explored theoretically in a manner comparable to 
the work described here.  Nonetheless, the data conformed in a general manner with 
theoretical expectations (25). 
 TIR-FCS has recently been used to examine the kinetics of fluorescently labeled 
bovine serum albumin and Thermomyces lanuginosus lipase with C18-coated glass in the 
presence of surfactants (24).  Again, it is difficult to compare the results reported in this 
work with the ones described herein, for several reasons.  First, the surfactants can act as 
inhibitors of surface adsorption both by competitively occupying surface binding sites 
and by directly interacting with the proteins in solution.  Also, in several of the 
measurements, free dye was present in addition to labeled proteins, photobleaching of 
tightly bound proteins was observed, the excitation intensities were high enough to 
produce photophysical effects at short times in the G(τ), and the systems were not at 
equilibrium.  Nonetheless, this work provides a good deal of useful information about 
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carrying out TIR-FCS when competitors are present (as well as providing information 
about the protein adsorption process itself) and highlights the need for a more thorough 
theoretical understanding of how TIR-FCS might be used to examine surface binding 
kinetics for mechanisms more complex than a simple, reversible association between 
fluorescent ligands in solution and non-fluorescent surface binding sites. 
 Enzyme kinetics at surfaces have also been investigated by using TIR-FCS (26).  
In these measurements, the reduction of dihydrorhodamine 123 to the highly fluorescent 
rhodamine 123, as catalyzed by immobilized horseradish peroxidase (HRP), was 
followed.  Single enzymes were located by using a CCD camera, and time-dependent 
fluorescence intensity data were obtained using a single-photon counting silicon 
avalanche photodiode.  The autocorrelated fluorescence data were fit to a 
phenomenological expression for G(τ) which contained a term describing the diffusion of 
fluorophores through the observation volume and two terms describing the enzyme 
kinetics.  For the last two terms, the multi-step enzyme mechanism was approximated as 
a unimolecular isomerization; one term was a stretched exponential with rate k1 
describing formation of the fluorescent enzyme-product complex and the other term was 
a simple exponential with rate k2 describing all other steps in the mechanism.  The total 
concentration of dihydrorhodamine 123 was ≈ 100-500 nM and the density of 
immobilized enzymes was 0.1 per μm2.  The value of Rz was measured in regions not 
containing enzymes and was found to be (18 μs)-1, which is somewhat higher than theory 
predicts even for fast rhodamine diffusion, but not completely unreasonable.  A result 
that is inconsistent with theoretical predictions was the measured G(0) values, which 
were higher in the presence relative to the absence of enzyme.  This inconsistency may be 
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a simple consequence that the work shows only representative G(τ) and not averages of 
G(0) from many positions.  The ratios of Gs(0) to Ga(0) were greater than one, more than 
adequate for measuring surface kinetics, and the values of G(0) were quite high enough 
(0.2-0.4) for good signal-to-noise ratios.  The measured values of k2 were ≈ 1000 s
-1 
and 
the measured values of k1 were ≈ 15000 s
-1
.  Particularly the k1 values do not comply 
with our criterion B, which may explain the somewhat fast measured value of Rz.  
Nonetheless, this work is seminal in that it demonstrates the ability of TIR-FCS to probe 
enzyme kinetics.  The work also indicates that further work describing the nature of TIR-
FCS kinetic data for different enzyme mechanisms is needed. 
 A series of three papers demonstrates the ability of TIR-FCS to probe the 
partitioning of fluorescent biomolecules between the cytoplasm and the inner face of the 
basal plasma membrane of adherent cells.  In the first work, membrane binding of 
farnesylated EGFP in HeLa cells was examined (7).  Autocorrelation data were analyzed 
with a model accounting for fast diffusion in solution coupled with slower diffusion on 
the membrane.  The fractions of the magnitudes of the measured G(τ) associated with 
solution and membrane diffusion were found to be 0.72 and 0.28, respectively; and the 
times Rr
-1
 associated with these fractions were 3.3 and 65 ms, respectively.  In a similar 
work, membrane binding of EGFP-conjugated protein kinase C in HeLa cells was 
examined (8).  The fractions of G(τ) associated with solution and membrane diffusion, 
and the associated times Rr
-1
, were 2.5 ms (0.82) and 160 ms (0.18).  After treatment with 
ATP, these parameters changed to 4.4 ms (0.69) and 140 ms (0.31), suggesting an ATP-
induced shift towards membrane binding.  The most important conclusion to be derived 
from these studies is that TIR-FCS can be successful in living cells.  In the third paper, 
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the work was extended by using seven different spatially separated observation volumes, 
each having its own photomuliplier as a detector (29).  This study represents a first step 
towards creating a kinetic map of intracellular dynamics occurring on or near basal cell 
membranes. 
 There is an important feature related to the application of TIR-FCS to live cells 
that becomes apparent when considering the results of these three studies in relation to 
the work described herein.  Possible contributions to G(τ) arising from 
association/dissociation kinetics at the cell membrane were not considered.  In its 
simplest form, TIR-FCS can provide information about association and dissociation 
kinetics only if the times related to these processes are faster than the times for diffusion 
on the surface through the observed area.  Because this area is usually required to be 
small to limit the average number of fluorescent molecules in the observation volume, 
obtaining information about on/off kinetics will be possible only if the membrane 
diffusion coefficient is slow enough and only through careful analysis as a function of the 
size of the observed area, to separate contributions from lateral mobility and surface 
binding kinetics.  In the work described above, the membrane diffusion coefficients were 
on the order of 10
-9
 cm
2
s
-1
 and the associated transport times were ≈ 150 ms; thus, only 
kinetic processes on the order of or faster than this time would be detectable.  However, 
in many cases, apparent membrane diffusion coefficients could be much slower, making 
measurement of dissociation rates and/or association kinetic rate constants more 
tractable. 
 An extensive study of paxillin dynamics in focal adhesions of migratory cells has 
recently been reported (30).  This work examined the behavior of EGFP-conjugated, 
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cytosolic paxillin in adherent CHO cells by using a large variety of state-of-the art 
fluorescence microscopy methods.  Of the many methods employed, one was TIR-FCS 
coupled not with a single-point detector but with a fast imaging camera.  This approach 
allows calculation of G(τ) from very many positions by auto-correlating the fluorescence 
fluctuations from single pixels (33).  In the paxillin study, because the frame acquisition 
rate was ≈ 100 Hz, temporal contributions to the G(τ) from diffusion of the labeled 
paxillin through the depth of the evanescent wave were largely excluded.  The G(τ) were 
fit to exponential decays (Eq. 2.11), yielding exchange rates that varied with position 
from 0.1 s
-1
 to 10 s
-1
.  By combining these results with those found from a number of 
other methods, considerable information about the role of paxillin in migratory cells was 
obtained.  This work demonstrates that imaging TIR-FCS is extremely promising in the 
context of creating “kinetic maps” for fluorescently labeled molecules reversibly 
associating with the inner face of the plasma membrane of adherent cells and correlating 
the observed kinetics with other molecular details of the plasma membrane. 
2.5.3 Expanded Range 
Upon review of the available experimental data, it becomes apparent that TIR-
FCS has been successfully carried for conditions that do not conform to our criteria 
(Table 2.2).  The most glaring discrepancy is in our definition of the minimum allowable 
value of Gs(0).  Therefore, we relaxed Criterion C and carried out calculations in which 
the minimum value of Gs(0) is not 0.05 but can also be 0.01, 0.005 or 0.001.  Tables 2.4 – 
2.7 show calculated quantities for the four considered values of [Gs(0)]min, six considered 
values of K, and X = 0.0001 or X = Xmax.  Table 2.4 shows S1, S2, S3, S4, Smax and the S 
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range.  Tables 2.5, 2.6 and 2.7 show predicted values of Gs(0), Gs(0)/Ga(0), and P, 
respectively, for the five surface site densities and the S range. 
Smax values denote the surface site densities for which Gs(0) is maximized; depend 
on d, X and K; and were calculated from Eq. 2.13.  The Smax values give an expression 
for the maximum value of Gs(0) which also depends on d, X and K (Eq. 2.14).  By setting 
this expression equal to [Gs(0)]min, one finds a maximum value of X, denoted by Xmax, 
which equals 
]
)]0([
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1
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2max
sGdh
K
X

 .      (2.26) 
In Tables 2.4 – 2.7, for a given value of K and [Gs(0)]min, the minimum value of X 
considered was 0.0001 and the maximum value of X was calculated from the above 
equation.  Surface site densities S1 and S2 denote the minimum and maximum values for 
which Gs(0) ≥ [Gs(0)]min, depend on K, X, d and h, and were calculated from the 
following generalization of Eq. 16: 
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Surface site densities S3 denote values below which Gs(0)/Ga(0) exceeds 0.1, depend on 
d, X and K, and were calculated from Eq. 2.18.  Surface site densities S4 denote values 
above which P ≥ 0.05, depend on S and X, and were found by numerically integrating Eq. 
2.19 with Eq. 2.20.  The range of allowable surface site densities was calculated as the 
maximum of S1 and S3 to the minimum of S2 and S4.  This range reflects the constraints 
that Gs(0) ≥ [Gs(0)]min, [Gs(0)/Ga(0)] ≥ 0.1, and P ≤ 0.05, and is not meant as an absolute 
requirement for successful TIR-FCS measurements.  Using surface site densities outside 
of this range will have the consequence of violating one of these three constraints and the 
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violation of these constraints may require analysis with a more sophisticated model than 
that shown in Eqs. 2.6 and 2.9-2.11. 
Table 2.4:  Surface Site Densities for Lower Values of Gs(0) 
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Table 2.5:  Gs(0) Values for Different Surface Site Densities 
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Table 2.6:  Gs(0)/Ga(0) Values for Different Surface Site Densities 
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Table 2.7:  Rebinding Probabilities P for Different Surface Site Densities 
 
 
 
In Tables 2.4 – 2.7 equilibrium constants K are in units of M-1, concentrations A are in units of 
nM, and surface site densities are in units of molecules/μm2.  Gs(0) values, Ga(0) values, X = KA 
values, and rebinding probabilities P are unit-less.  In all cases, it has been assumed that d = 0.1 
μm, h = 0.5 μm, D = 50 μm2s-1 and ka = 10
6
 M
-1
s
-1
.  Data are given for the four cases in which the 
minimum tolerable value of Gs(0), denoted by [Gs(0)]min, is 0.05, 0.01, 0.005 or 0.001. 
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By comparing the material in Tables 2.4 – 2.7 with that in Table 2.3 and Eqs. 
2.13-2.18, the following conclusions can be made:  1) The values of X = KA can be 
considerably higher if it is possible to work at lower values of Gs(0) than those specified 
by Criterion C.  For example, if the minimum allowed value of Gs(0) is 0.001, for K = 
10
7
 M
-1
, X values as high as 6.8 can be tolerated, and for K = 3 x 10
4
 M
-1
, X values up to 
0.14 are predicted to be tolerable.  These higher values of X would make it more likely 
that ka, in addition to kd, could be measured.  Higher X values would also facilitate 
measurement of a broader range of K values by using either Fpos(A) and Fneg(A), or 
Gpos(0) and Gneg(0).  2) The minimum and maximum values of the surface site densities 
set by the minimum value of Gs(0), S1 and S2, are lower and higher, respectively, for 
given values of K and X.  3) The surface site densities at which Gs(0) is maximized, Smax, 
do not change.  4) The minimum surface site densities set by Criterion D, S3, do not 
change.  5) The rebinding probabilities P depend only on S, X, ka and D.  Thus, changing 
Criterion C does not change the maximum surface site densities S4 set by Criterion E.  6) 
Reducing the minimum allowed value of Gs(0) changes the ratios Gs(0)/Ga(0) in a rather 
complex manner.  However, this ratio is still always much greater than 0.1, for the 
conditions considered, when S = Smax.  7) The rebinding probabilities also change, but are 
often very low, remain equal to 0.05 when S = S4, and are always less than 0.05 when S = 
Smax. 
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2.5.4 Future Directions 
 The use of TIR-FCS to quantify the thermodynamic and kinetic parameters 
governing the reversible association of fluorescent ligands with non-fluorescent surface 
binding sites shows great promise.  However, the large number of parameters that affect 
the ability of TIR-FCS to provide information about surface binding kinetics complicates 
experimental design.  The work described herein provides a comprehensive guide that 
addresses this issue.  The theoretical predictions should be testable by careful in vitro 
measurements as a function of K, ka, kd, A, S, d, h, D and the excitation intensity.  Only a 
simple reversible bimolecular reaction between soluble, fluorescent ligands and laterally 
immobile, non-fluorescent surface binding sites has been addressed here, but in many 
cases a more complex situation will be of interest.  However, understanding this first 
simple mechanism in the context of TIR-FCS is a pre-requisite for extension to more 
complex processes, the need for which becomes evident after reviewing prior, related 
experimental results.  Three extensions of interest are as follows:  1) the use of a single 
fluorescent reporter in solution to examine the thermodynamic and kinetic parameters 
describing the interaction of soluble, non-fluorescent molecules that compete with the 
fluorescent reporters for occupation of the surface binding sites; 2) the use of a single 
fluorescent reporter in solution to examine the thermodynamic and kinetic parameters 
describing the interaction of soluble, non-fluorescent molecules with the surface binding 
sites that subsequently inhibits or enhances the interaction of the fluorescent reporters 
with the surface binding sites; and 3) the use of a single fluorescent reporter in solution to 
investigate its interaction with soluble, non-fluorescent molecules that inhibit or enhance 
the interaction of the fluorescent reporter with the surface binding sites.  All three of 
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these extensions are quite important for processes in which the non-fluorescent molecules 
of interest are too small to be directly conjugated to a fluorophore without perturbing the 
values of the parameters of interest.  As described above, additional extensions of interest 
include application of TIR-FCS to enzyme kinetics; multivalent, fluorescent ligands; and 
cellular or other processes in which the binding sites are laterally mobile. 
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Chapter 3 
 
Rifampicin – independent interactions between the pregnane X receptor 
ligand binding domain and peptide fragments of co-activator and co-
repressor proteins 
 
3.1 PXR as a Potential Test System for TIR-FCS 
 As discussed in the introduction, theoretical work predicted that TIR-FCS can 
yield thermodynamic and kinetic information about nonfluorescent molecules that bind 
surface binding sites and in so doing, alter the binding of fluorescent reporters to the 
same sites.  Two types of nonfluorescent ligands have been defined: 1) nonfluorescent 
effectors bind surface-bound receptors and allosterically enhance the binding of 
fluorescent ligands to these receptors; while 2) nonfluorescent competitors compete with 
fluorescent ligands to bind surface-bound receptors. 
 To test the theoretical predictions relating to TIR-FCS and nonfluorescent 
effectors, we set out to establish a model system consisting of a nuclear receptor called 
the pregnane X receptor (PXR), peptides derived from one of its co-activator proteins and 
an established PXR agonist, rifampicin.  Nuclear receptors are transcription factors and 
the existing model of nuclear receptor action states that upon binding agonists, nuclear 
receptors preferentially associate with co-activators, which in turn recruit downstream 
members of the cell’s transcription machinery. 
Sections 3.2 – 3.8 reproduced with permission from: Navaratnarajah, P., Steele, B. L., Redinbo, 
M. R., Thompson, N. L. (2011) Biochemistry, 15, 19-31. Copyright 2011 American Chemical 
Society. 
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 We established an experimental system in which PXR, immobilized on a 
neutravidin-coated fused silica surface, served as a surface binding site, while a 
fluorescently labeled peptide derived from the steroid receptor co-activator 1 (SRC-1) 
served as a fluorescent reporter.  Rifampicin was to act as a nonfluorescent effector.  As 
the interaction among PXR, its co-activators and agonists had not been biophysically 
characterized prior to our work, we used established techniques, TIRFM and TIRFM 
combined with fluorescence recovery after photobleaching, to obtain the thermodynamics 
and kinetics of PXR interacting with fluorescently labeled SRC-1 peptide in the presence 
and absence of rifampicin.  Much to our surprise, rifampicin did not act as an effector and 
increase PXR’s affinity for the co-activator peptide.  These findings have significant 
implications for the existing model of PXR action and are the subject of this chapter. 
 It goes without saying that PXR and its interacting partners cannot serve as a 
model to test whether TIR-FCS yields kinetic information about nonfluorescent effectors.  
However, during the course of our work we found that peptides derived from co-
repressor proteins compete with co-activators to bind PXR.  Moreover, co-activators and 
co-repressors interact with PXR with equilibrium dissociation constants that are 
significantly different, making PXR and its co-regulators a suitable model with which to 
test theoretical predictions pertaining to nonfluorescent competitors.  These proteins can 
also be used to test experimental conditions detailed in Chapter 2 that were predicted to 
yield autocorrelation curves containing significant thermodynamic and kinetic 
information about relevant ligand-receptor interactions. 
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3.2 Overview 
The pregnane X receptor (PXR), a member of the nuclear receptor superfamily, 
regulates the expression of drug-metabolizing enzymes in a ligand-dependent manner.  
The conventional view of nuclear receptor action is that ligand binding enhances the 
receptor’s affinity for co-activator proteins, while decreasing its affinity for co-repressors.  
To date, however, no known rigorous biophysical studies have been conducted to 
investigate the interaction between PXR, its co-regulators and ligands.  In the present 
work, steady-state total internal reflection fluorescence microscopy (TIRFM) and total 
internal reflection with fluorescence recovery after photobleaching were used to measure 
the thermodynamics and kinetics of the interaction between the PXR ligand binding 
domain and a peptide fragment of the steroid receptor co-activator-1 (SRC-1) in the 
presence and absence of the established PXR agonist, rifampicin.  Equilibrium 
dissociation and dissociation rate constants of about 5 µM and 2 s
-1
, respectively, were 
obtained both in the presence and absence of rifampicin, indicating that the ligand does 
not enhance the affinity of the PXR and SRC-1 fragments.  Additionally, TIRFM was 
used to examine the interaction between PXR and a peptide fragment of the co-repressor 
protein, the silencing mediator for retinoid and thyroid receptors (SMRT).  An 
equilibrium dissociation constant of about 70 µM was obtained for SMRT in the presence 
and absence of rifampicin.  These results strongly suggest that the mechanism of ligand-
dependent activation in PXR differs significantly from that seen in many other nuclear 
receptors. 
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3.3 Introduction 
The nuclear receptor superfamily consists of structurally related proteins that 
regulate the transcription of target genes in a ligand-dependent manner.  Nuclear 
receptors, which include the estrogen, androgen, thyroid and vitamin D receptors, 
regulate a variety of biological processes including reproduction, development, 
metabolism and energy homeostasis, in response to various hydrophobic ligands.  The 
pregnane X receptor (PXR), a member of the nuclear receptor superfamily, protects the 
body from potentially toxic compounds by regulating the expression of proteins that 
metabolize and excrete these compounds from cells (1). 
PXR binds promiscuously to a wide variety of compounds including naturally 
occurring steroids, hormones and bile acids, as well as exogenous ligands like 
insecticides, herbal extracts and pharmaceutical products (1).  PXR has been implicated 
in adverse drug-drug interactions, whereupon being activated by a drug, PXR promotes 
the expression of enzymes that metabolize the activating drug, as well as other co-
administered therapeutics.  Such adverse effects have been observed with hyperforin, a 
constituent in the herbal product St. John’s Wort, and rifampicin, an antibiotic, both of 
which have been shown to bind and activate PXR (2-7). 
PXR works in concert with its heterodimerization partner, the retinoid X receptor 
(RXR), to bind promoter regions of target genes and co-activators like the steroid 
receptor co-activator-1 (SRC-1).  The PXR-RXR-co-activator-DNA complex then 
recruits and directs downstream members of the transcription machinery (5, 6).  Crystal 
structures of several nuclear receptor ligand binding domains (LBDs) in the apo- and 
ligand-bound states indicate that in the presence of an agonist, an α-helix at the C-
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terminus called activation function-2 (AF-2) undergoes a conformational change that 
allows nuclear receptors to bind co-activators (8-11).  Specifically, in the active 
conformation nuclear receptors form a critical charge clamp with conserved LXXLL 
motifs (where X is any amino acid) found in co-activators (11, 12). 
In the absence of ligand, the transcriptional activity of nuclear receptors is, in part, 
downregulated by the action of co-repressor proteins.  The nuclear receptor co-repressor 
known as the silencing mediator of retinoid and thyroid receptors (SMRT) has been 
shown to repress both the basal and ligand-induced transcriptional activity of PXR (13-
15).  Co-repressors bind nuclear receptors via receptor interaction domains containing 
conserved LXXXIXXXL motifs and recruit proteins, including histone deacetylases, that 
suppress transcription.  A crystal structure of a nuclear receptor (peroxisome proliferator-
activated receptor-α) LBD in complex with a peptide fragment of SMRT shows that the 
AF-2 is displaced from its active confirmation upon co-repressor binding (16).  Co-
repressors thereby inhibit the transcriptional activity of nuclear receptors by preventing 
the recruitment of co-activators. 
This paper provides a biophysical assessment of the interaction between PXR-
LBD and peptides derived from the co-activator, SRC-1, and the co-repressor, SMRT, in 
the presence and absence of the well established PXR agonist, rifampicin.  For the first 
time, we report equilibrium constants for PXR-LBD/co-regulator interactions and 
dissociation rate constants for the PXR-LBD/SRC-1 interaction measured by steady-state 
total internal reflection fluorescence microscopy [TIRFM; (17-20)] and total internal 
reflection with fluorescence recovery after photobleaching [TIR-FRAP; (21-23)], 
respectively.  This quantitative information strongly suggests that the mode of ligand-
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dependent activation of PXR differs from that of most other nuclear receptors studied to 
date. 
3.4 Materials and Methods 
3.4.1 PXR-LBD Cloning, Expression, Purification and Labeling 
The LBD of human PXR (residues 130-434; see Figure 3.1) was expressed as a 
fusion protein with an amino-terminal AviTag™ and His6 tag (for purification).  The 
AviTag™ allows for the specific biotinylation of the tagged protein by the Escherichia 
coli enzyme BirA.  A codon-optimized version of the PXR-LBD gene (GenScript USA, 
Piscataway, NJ) was cloned into pET21c(+) between NdeI and HindIII, along with an N-
terminal AviTag™ sequence (Avidity, Denver, CO) followed by a His6 sequence.  With 
this insert, two stop-codons were introduced upstream of the C-terminal His6 tag 
normally found in pET21c(+).  PXR-LBD was co-expressed with an 88-amino acid 
fragment of SRC-1 to enhance PXR stability.  The SRC-1 fragment (residues 623-710), 
along with the T7 promoter, had been previously inserted into the pACYC184 vector at 
the HindIII and BamHI sites (24, 25). The pET21c-AviTag-His6-PXR-LBD and 
pACYC184-SRC-1 plasmids were co-transformed into the BL21 DE3 Gold E. coli strain. 
 
 
Figure 3.1:  Domain Organization of PXR.  Activation function 1 (AF-1) is situated at the N-
terminus.  AF-1 has been shown to mediate ligand-independent transcriptional activity in some 
nuclear receptors.  AF-1 is followed by the DNA binding domain (DBD) and ligand binding 
domain (LBD).  The numbers refer to amino acids. 
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Terrific Broth (3 L) supplemented with ampicillin (100 µg/mL) and 
chloramphenicol (35 µg/mL) was inoculated with an overnight culture (0.5% innoculant).  
Cells were grown at 37 ⁰C to an OD600 of ~2.7 and induced with 0.1 mM isopropyl β-D-
thiogalactopyranoside at 18 ⁰C for ~16 h.  Cells were harvested by centrifugation (30 
min, 3500 g, 4 ⁰C) and stored at -80 ⁰C.  Cell pellets (~ 25 g) were resuspended in 125 
mL of Buffer A [20 mM Tris, pH 7.9, 250 mM NaCl, 5% glycerol, 20 mM imidazole, 0.1 
mM Tris(2-carboxyethyl)phosphine (TCEP; Soltec Ventures, Beverly, MA)] 
supplemented with three protease inhibitor tablets (complete, EDTA-free, Roche 
Diagnostics, Mannheim, Germany) and DNase (50 μg/mL; Worthington Biochemical 
Corp., Lakewood, NJ), and then subjected to Dounce homogenization.  Cell homogenates 
were tip sonicated on ice and the cell lysates were then clarified by centrifugation (45 
min, 27000 g, 4 ⁰C).  The clarified cell lysates were incubated with 750 µL of His-
Select® Ni resin (Sigma-Aldrich, St. Louis, MO) equilibrated in Buffer A for 1 h at 4 ⁰C.  
The resin was subsequently washed with 125 mL of Buffer B (20 mM Tris, pH 7.9, 500 
mM NaCl, 5% glycerol, 20 mM imidazole).  PXR-LBD was eluted using six aliquots of 1 
mL each of Buffer C (20 mM Tris, pH 7.9, 250 mM NaCl, 5% glycerol, 2 mM TCEP, 
300 mM imidazole).  Protein fractions were combined and dialyzed against Buffer D (20 
mM Tris, pH 7.9, 250 mM NaCl, 5% glycerol, 2 mM TCEP) at 4 ⁰C.  Thereafter, PXR-
LBD was quickly frozen in liquid N2 and stored at -80 ⁰C in 1 mL aliquots at a 
concentration of 0.1 mg/mL. 
The AviTag-His6-PXR-LBD fusion protein, henceforth referred to as PXR-LBD, 
is 38,750 Da with an extinction coefficient at 280 nm of 34,080 M
-1
cm
-1
 (26).  Protein 
concentrations were measured by using both absorbance at 280 nm and the Bradford 
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Assay (Bio-Rad Laboratories, Hercules, CA).  SDS-PAGE with Coomassie Brilliant Blue 
and silver stains indicated that the primary band was at the molecular weight expected for 
PXR-LBD and impurities were negligible.  Silver stained gels showed no bands close to 
or at 10 kDa, suggesting that the co-expressed, 9.8 kDa SRC-1 fragment was removed 
during PXR purification.  Western blots with anti-biotin antibodies conjugated to horse 
radish peroxidase (Cell Signaling Technology, Beverly, MA) were used to confirm in 
vivo biotinylation.  The molar ratio of biotin to PXR-LBD, as estimated by using Pierce® 
Biotin Quantitation Kit (Thermo Scientific, Rockford, IL), ranged from 0.7 to 1.3, 
indicating that a majority of the protein was biotinylated. 
For some control measurements, PXR-LBD was fluorescently labeled with an 
amine reactive dye, Alexa Fluor® 488 5-TFP (Invitrogen, Carlsbad, CA).  Briefly, PXR-
LBD eluted from the Ni affinity column during purification was concentrated to about 1.5 
mg/mL and incubated with a 10-15 molar excess of the dye for 2 h at 4 ⁰C with 
continuous, gentle stirring.  Free dye was removed by passing the solution through an 
anion exchange column (4 mL) constructed from Dowex® 1X8 resin (Acros Organics, 
Morris Plains, NJ) and equilibrated in 10 mM sodium phosphate, 5% glycerol, pH 5.3.  
Protein was immediately dialyzed against Buffer D.  The molar ratio of dye to protein, as 
determined by the relative absorptivities at 280 and 494 nm, was approximately 0.3.  As 
before, protein aliquots were frozen in liquid N2 and stored at -80 ⁰C. 
A ligand-bound mimic of PXR-LBD was made by mutating two residues in the 
ligand binding pocket to tryptophans: S247W and C284W (27).  The mutations were 
made sequentially using the QuikChange-II Site-Directed Mutagenesis Kit (Stratagene, 
La Jolla, CA) according to the manufacturer’s protocol.  The following primers (with 
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underlining indicating mutated nucleotides) were used for the S247W mutation: forward 
5’-gcacatggcagatatgTGGacctatatgttcaaaggc-3’ and reverse 5’-gcctttgaacatataggtCCAcat 
atctgccatgtgc-3’; and for the C284W mutation: forward 5’-gcagcgtttgaactgTTGcagctgcgt 
ttcaac-3’ and reverse 5’-gttgaaacgcagctgCCAcagttcaaacgctgc-3’.  Mutations were 
generated using the pET21c-AviTag-His6-PXR-LBD plasmid as template, and confirmed 
by sequencing.  PXR-LBD (S247W/C284W) was expressed and purified as described 
above for wild type PXR-LBD. 
3.4.2 Co-regulator Peptide Synthesis and Fluorescence Labeling 
A 25 amino acid fragment of SRC-1 (676-CPSSWSSLTERHKILHRLLQEGSPS 
-700) was synthesized at the UNC Microprotein Sequencing and Peptide Synthesis 
Facility.  Residue 680 was mutated from histidine to tryptophan (H680W) to facilitate 
peptide quantification.  The average and monoisotopic molecular weights of the peptide 
are 2849.18 and 2847.44 g/mol, respectively.  The molar absorptivity of the peptide at 
280 nm is 5810 M
-1
cm
-1
.  The N-terminal cysteine residue was fluorescently labeled with 
a thiol-reactive dye, fluorescein C5 maleimide (AnaSpec, Fremont, CA).  Briefly, peptide 
(5 mg, 1.8 µM), a 2-fold molar excess of TCEP and 4-fold molar excess of dye were 
combined in 50 mM sodium phosphate, pH 7.6.  The reaction mixture was stirred under 
argon for ~5 h at room temperature, and an additional ~19 h at 4 ⁰C.  Free dye was 
removed by passing the mixture through an anion exchange column (4 mL) constructed 
from Dowex® 1X8 resin, both equilibrated and washed with 50 mM sodium acetate, pH 
5.0.  The peptide was further purified using HPLC to remove salts.  Briefly, a 0 to 40% 
gradient of Solvent B (95% acetonitrile, 5% water, 0.1% trifluoroacetic acid) in Solvent 
A (95% water, 5% acetonitrile, 0.1% trifluoroacetic acid) was generated on an Atlantis 
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dC18 (10 x 100 mm) column and Waters HPLC with Delta 600 pumps (Waters Corp., 
Milford, MA) at a flow rate of 4 mL/min.  Peptide fractions were combined, lyophilized 
and stored at -20 ⁰C.  Peptide labeling was confirmed by mass spectrometry.  The molar 
ratio of fluorescein to peptide was determined by using the absorptivities at 280 nm and 
494 nm.  Labeling ratios ranged from 0.35 to 0.50.  The fluorescently labeled SRC-1 
peptide is henceforth denoted as F-SRC-1.  Labeled and unlabeled peptides were mixed 
to form an overall F-SRC-1 labeling ratio of 0.10, unless otherwise indicated. 
Peptide fragments of SMRT (2337-TNMGLEAIIRKALMGKYDQWEE-2358) 
and of a second co-repressor protein, called the nuclear receptor co-repressor (NCoR, 
2251-GHSFADPAS-NLGLEDIIRKALMGSF-2275) were synthesized at the UNC 
Microprotein Sequencing and Peptide Synthesis Facility.  The concentration of SMRT 
(2337 – 2358) was determined spectrophotometrically using the peptide’s extinction 
coefficient at 280 nm, 6970 M
-1
cm
-1
.  The concentration of NCoR (2251 – 2275) was 
determined by measuring the mass of the lyophilized peptide. 
3.4.3 Other Reagents 
D-Biotin (Acros Organics, Morris Plains, NJ), unreactive fluorescein reference 
standard (Invitrogen, Eugene, OR), NeutrAvidin (Thermo Scientific, Rockford, IL), 
ovalbumin (Sigma-Aldrich, St. Louis, MO), and rifampicin (Fisher Scientific, Fairlawn, 
NJ) were obtained commercially.  Concentrations for the last four reagents were 
determined spectrophotometrically by using the following extinction coefficients: 
fluorescein, 68,000 M
-1
cm
-1
, 494 nm; NeutrAvidin, 99,600 M
-1
cm
-1
, 280 nm; ovalbumin, 
31,500 M
-1
cm
-1
, 280 nm; and rifampicin, 26,400 M
-1
cm
-1
, 334 nm.  For some control 
measurements, NeutrAvidin was fluorescently labeled with Alexa Fluor® 488 5-TFP 
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(Invitrogen, Carlsbad, CA).  NeutrAvidin (2 mg/mL) and a 5-fold molar excess of dye 
were dissolved in 100 mM sodium phosphate, pH 8.0.  The mixture was incubated at 25 
⁰C for 1 h with continuous, gentle stirring.  Thereafter, free dye was removed by passing 
the mixture through an anion exchange column (4 mL) constructed from Dowex® 1X8 
resin and equilibrated in 100 mM sodium acetate, 500 mM NaCl, pH 4.0.  Labeled 
protein was dialyzed against Buffer D.  The molar ratio of dye to protein, determined 
spectrophotometrically, was approximately 0.7. 
3.4.4 Sample Preparation 
Immediately before use, all protein samples were centrifuged (~100,000 g, 30 
min; Airfuge; Beckman-Coulter, Fullerton, CA) to remove possible aggregates.  
NeutrAvidin and ovalbumin were filtered (0.1 µm, 13 mm, Anatop; Whatman, GE 
Healthcare, Piscataway, NJ) following centrifugation.  Microscope (3 in. x 1 in. x 1 mm; 
Gold Seal® Products, Porstmouth, NH) and fused silica (0.25 in. x 1 in. x 1 mm; Quartz 
Scientific, Fairport Harbor, OH) slides were cleaned by boiling in ICN detergent (MP 
Biomedicals, Solon, OH) diluted in water, bath sonicating, rinsing extensively in 
deionized water, and drying at 120 ⁰C.  Immediately prior to collecting data, the 
substrates were further cleaned in an argon ion plasma cleaner (PDC-3XG; Harrick 
Scientific, Ossining, NY) for 15 min at room temperature.  Fused silica slides were 
mounted on microscope slides using double sided, 0.13 mm thick, tape (part no. 021200-
64988; 3M Corp., St. Paul, MN).  NeutrAvidin/ovalbumin (0.5/0.1 mg/mL in Buffer D, 
60 µL) was applied to the space between the fused silica and microscope slides.  Slides 
were incubated at room temperature for 1 h, allowing the NeutrAvidin and ovalbumin to 
coat the surfaces of the substrates.  Excess protein was removed by washing the inner 
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sample chambers with Buffer D (200 µL, x 10).  NeutrAvidin/ovalbumin – coated sample 
chambers were treated with PXR-LBD (0.1 mg/mL in Buffer D, 200 µL) for 5 min at 
room temperature and washed with Buffer D (200 µL, x 10) to remove excess PXR.  For 
steady-state TIRFM and TIR-FRAP measurements to obtain F-SRC-1/PXR-LBD 
equilibrium and dissociation rate constants, solutions (200 µL) containing F-SRC-1 and 
ligand in Buffer D at the indicated concentrations were applied to the sample chambers.  
Immediately thereafter, samples were mounted onto the microscope for data collection.  
For competition curves to obtain SMRT/PXR-LBD equilibrium constants, solutions (200 
µL) containing 5 µM F-SRC-1, rifampicin and SMRT in Buffer D at the indicated 
concentrations were applied to the sample chambers.  SMRT was replaced with a peptide 
fragment of the co-repressor, NCoR, in some measurements. 
3.4.5 Fluorescence Microscopy 
Steady-state TIRFM and TIR-FRAP were carried out using the equipment 
described below.  A through-prism TIRFM apparatus was used to generate evanescent 
illumination with an elliptically Gaussian spatial profile having 1/e
2
- radii of wx = 22.4 ± 
0.5 μm and wy = 65.0 ± 0.4 μm, respectively (28).  Measurements were conducted using 
an argon ion laser (Innova 90-3; Coherent, Palo Alto, CA), an inverted microscope (Zeiss 
Axiovert 35; Carl Zeiss Inc., Thornwood, NY) with a 40x, 0.55 numerical aperture, long 
working distance objective (Nikon Instruments Inc., Nelville, NY) and an avalanche 
photodiode (SPCM-AQ-151; EG&G Optoelectronics, Quebec, Canada) detector.  An in-
house LabVIEW program and DAQ board (PCI-MIO-16XE-50, National Instruments, 
Austin, TX) were used to control the instruments.  Fluorescence was excited at 488 nm 
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and detected through a dichroic mirror and barrier filter, at room temperature.  All data 
were fitted in SigmaPlot 11.0 (Systat Software Inc., San Jose, CA). 
3.4.6 Steady-State Total Internal Reflection Fluorescence Microscopy 
Steady-state TIRFM (17-19) was used to measure equilibrium dissociation 
constants for the interaction between F-SRC-1/PXR-LBD and SMRT/PXR-LBD under 
different conditions, including at different rifampicin concentrations.  All samples were 
evanescently illuminated and the surface-associated fluorescence was measured using a 
PC-based correlator board (ALV-5000/E, ALV, Langen, Germany).  Fluorescence 
intensities, averaged over 10 s, were measured at eight distinct sites on a given sample. 
To characterize the F-SRC-1/PXR-LBD interaction, the surface-associated 
fluorescence of samples was measured as a function of the F-SRC-1 concentration in 
solution.  The measured surface-associated fluorescence was assumed to be proportional 
to the average density of fluorescent molecules bound to surface binding sites (PXR-
LBD), as well as the average density of such molecules diffusing in the evanescent wave.  
To obtain the fluorescence associated with F-SRC-1/PXR-LBD complexes alone, 
fluorescence measured in the absence of PXR-LBD was subtracted from the total 
fluorescence.  This background-corrected fluorescence was plotted as a function of the F-
SRC-1 concentration, and fit to a model of single-site binding to obtain an apparent 
equilibrium dissociation constant. 
Competition curves were used to determine the equilibrium dissociation constant 
for the interaction between PXR-LBD and co-repressor peptides.  TIRFM was used to 
measure the surface-associated fluorescence arising from 5 µM F-SRC-1 reversibly 
interacting with surface-immobilized PXR-LBD in the presence of an increasing 
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concentration of co-repressor peptide.  The co-repressor competed with F-SRC-1 to bind 
PXR-LBD and a corresponding decrease in the surface-associated fluorescence was 
observed.  Background, arising from fluorescence due to the diffusion of free F-SRC-1 in 
the evanescent wave, was subtracted and the data were fit to an appropriate model (see 
Results) to obtain the equilibrium dissociation constant for the interaction between the 
PXR and co-repressor fragments. 
3.4.7 Total Internal Reflection with Fluorescence Recovery After 
Photobleaching 
TIR-FRAP (21, 22, 29, 30) was used to measure the apparent dissociation rate 
constant for the F-SRC-1/PXR-LBD interaction.  In this technique, an evanescently 
illuminated area is photobleached, and the subsequent fluorescence recovery is observed 
as a function of time.  Fluorescence recovery, which occurs when photobleached 
molecules on the surface are replaced by unbleached molecules from solution, is 
proportional to the intrinsic rate at which photobleached molecules dissociate from 
surface binding sites, in the absence of surface rebinding.  Recovery curves were fit to an 
appropriate exponential model to obtain the off-rate for the F-SRC-1/PXR-LBD 
interaction (see Results for more detail).  TIR-FRAP measurements were conducted using 
bleach pulses with intensities of 100 to 300 mW and associated bleach times of 100 to 50 
ms, respectively.  Fluorescence recovery was monitored for 30 s after photobleaching. 
3.5 Results 
TIRFM and related techniques specifically allow one to probe the behavior of 
fluorescent species close to or at interfaces.  Therefore, we immobilized biotinylated 
PXR-LBD on NeutrAvidin-coated microscope slides via the biotin-avidin linkage.  
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TIRFM-based techniques were used to examine co-activator and co-repressor peptides in 
solution reversibly interacting with surface-bound PXR-LBD, in the presence and 
absence of rifampicin. 
3.5.1 Control Measurements 
It was necessary, first, to confirm that NeutrAvidin and PXR-LBD were 
irreversibly bound to the surface.  To probe the surface life-time of NeutrAvidin, 
fluorescently labeled NeutrAvidin (0.5 mg/mL) along with ovalbumin (0.1 mg/mL) was 
immobilized on microscope slides, the slides were then washed, and the surface-
associated fluorescence was monitored for 90 min at 30 min intervals using TIRFM (data 
not shown).  Although the fluorescence decreased 13 ± 3 % over the first 30 min period, 
no further decrease was observed.  To probe the surface life-time of PXR-LBD, slides 
were coated with a mixture of NeutrAvidin (0.5 mg/mL) and ovalbumin (0.1 mg/mL), 
washed, treated with fluorescently labeled PXR-LBD (0.1 mg/mL), washed, and then the 
surface-associated fluorescence was monitored for 90 min at 30 min intervals using 
TIRFM (data not shown).  Although the fluorescence decreased 13 ± 3 % over the 90 min 
period, the decrease was only 3 ± 3 % after 30 min.  As all TIRFM equilibrium and TIR-
FRAP kinetic measurements, for individual samples, were obtained within at least 30 min 
after the final wash, the calibrated surface residency times for NeutrAvidin and PXR 
were judged to be sufficient. 
PXR-LBD was biotinylated at its N-terminal, away from the ligand binding 
pocket, the SRC-1 peptide binding site, the SMRT binding site and AF-2 (7, 25), to 
minimize the possibility that biotinylation and subsequent immobilization would affect 
the interaction with ligands and co-regulators.  To determine whether PXR-LBD 
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specifically bound NeutrAvidin during surface immobilization, fluorescently labeled 
PXR-LBD (F-PXR-LBD) was applied to NeutrAvidin-coated substrates in the presence 
and absence of excess (100 µM) d-biotin.  Figure 3.2 shows that in the presence of excess 
d-biotin the surface-associated fluorescence decreased markedly, indicating that F-PXR-
LBD specifically bound NeutrAvidin.  All subsequent measurements were conducted at 
PXR-LBD concentrations of 0.1 mg/mL. 
 
Figure 3.2:  Specificity of PXR-LBD Immobilization.  The surface-associated fluorescence of 
F-PXR-LBD bound to immobilized NeutrAvidin was measured, after treating surfaces in the 
(triangles) presence and (circles) absence of 100 μM d-biotin.  The molar ratios of d-biotin to 
PXR-LBD ranged from approximately 400 (0.01 mg/mL PXR-LBD) to 40 (0.1 mg/mL PXR-
LBD).  Fluorescence was measured after incubating F-PXR-LBD with surface-bound 
NeutrAvidin for 5 min and washing with 2 mL of Buffer D.  Mean values from three separate 
samples (obtained from eight points per sample) were averaged to generate the above curve.  
Uncertainties are standard deviations associated with the three-fold averages.  All subsequent 
measurements were carried out with 0.1 mg/mL PXR-LBD. 
 
PXR has the ability to bind many types of ligands, and in the measurements 
reported here, the SRC-1 peptide was labeled with fluorescein maleimide.  To ensure that 
fluorescein is not a PXR ligand, the surface-associated fluorescence as a function of the 
concentration of unreactive fluorescein reference standard in solution was examined in 
the presence and absence of surface-bound PXR-LBD (data not shown).  Data were 
obtained for fluorescein concentrations ranging up to 9 µM, above the maximum 
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concentration of labeled F-SRC-1 used in subsequent measurements (usually 3.5 µM).  
The evanescently excited fluorescence intensities measured in the presence and absence 
of PXR-LBD were identical and linear with the fluorescein concentration indicating that 
the fluorescence arose solely from fluorescein in solution and that, therefore, fluorescein 
is not a PXR ligand. 
3.5.2 F-SRC-1/PXR-LBD Equilibrium Dissociation Constants Measured by 
Steady-State TIRFM 
Steady-state TIRFM was used to examine the thermodynamics of the interaction 
between F-SRC-1 and PXR-LBD at different rifampicin concentrations.  The surface-
associated fluorescence arising from both F-SRC-1 bound to immobilized PXR-LBD and 
free F-SRC-1 in solution that were close enough to the surface to be excited by the 
evanescent field, denoted by F(+), was measured as a function of the F-SRC-1 
concentration in solution.  Also measured was the fluorescence solely from F-SRC-1 in 
solution, denoted by F(-), obtained from samples not treated with PXR-LBD.  The 
difference, which gives a measure of the density of specifically bound F-SRC-1, is 
denoted by F(+) - F(-).  These three quantities are, in the simplest case, given by 
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In Eq. 3.1, Q is a proportionality constant, S is the surface density of PXR-LBD, A is the 
solution concentration of F-SRC-1 (only 10% or 30% of which is actually labeled), Kd is 
the equilibrium dissociation constant describing the reversible association of F-SRC-1 
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with PXR-LBD, d is the depth of the evanescent field, and b is a constant background 
signal. 
For a given, matched set of measured F(+) and F(-) intensities (see Figure 3.3A), 
the following procedure was used to find the best-fit value of the equilibrium dissociation 
constant Kd.  The experimentally determined values of F(-) were fit to the second 
expression in Eq. 3.1 with A as the abscissa, and Qd and b as free parameters.  The best-
fit values of Qd and b were used to calculate theoretical values for F(-) for the values of 
A at which F(+) intensities had been obtained.  The theoretical values of F(-) were 
subtracted from the experimental values of F(+) (see Figure 3.3B).  The fluorescence 
differences were then fit to the third expression in Eq. 3.1 with QS and Kd as free 
parameters.  A representative binding curve from a single trial is shown in Figure 3.3. 
 
Figure 3.3:  Representative F-SRC-1/PXR-LBD Binding Isotherm.  These plots, obtained 
from a single trial, show the surface-associated fluorescence of F-SRC-1 interacting with PXR-
LBD in the presence of 1 μM rifampicin:  A) Representative values of F(+) (closed circles) and 
F(-) (open circles); B) Background-subtracted data, F(+) – F(-), curve-fit to the third expression 
in Eq. 3.1, which yields a Kd of 4.5 ± 1.4 µM, where the error is that associated with the fit.  The 
PXR-LBD surface site density is 2.0 ± 0.2 x 10
3
 molecules/μm2. 
 
Equilibrium dissociation constants pertaining to the F-SRC-1/PXR-LBD 
interaction, obtained at rifampicin concentrations that ranged from 0 to 100 µM, are 
tabulated in Table 3.1.  As the reported equilibrium dissociation constants for rifampicin 
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and PXR-LBD are ≤ 10 µM (31, 32), at 100 µM rifampicin one would expect most (≥ 
91%) of the surface-immobilized PXR-LBD to be in the ligand-bound state.  The 
measured dissociation constants are within error of each other, indicating that rifampicin 
does not affect the affinity of the receptor for F-SRC-1.  To verify these results, binding 
curves were obtained where the surface-associated fluorescence was measured as a 
function of the rifampicin concentration, ranging from 0 to 100 µM (data not shown).  In 
these measurements, the F-SRC-1 was kept constant at 2.5 µM.  The surface-associated 
fluorescence did not change, within experimental uncertainty, with the rifampicin 
concentration, supporting our previous results that rifampicin does not affect the 
interaction between the PXR-LBD and SRC-1 fragment.  A PXR-LBD mutant 
(S247W/C284W), which was made to mimic a ligand-bound state of the receptor by 
introducing bulky tryptophan residues into the ligand binding pocket (27), served as a 
control.  Many such mutants have been shown to constitutively recruit co-activator and 
promote the transcription of reporter genes in a ligand-independent manner (7, 27).  The 
present measurements indicate that the F-SRC-1 peptide interacts with PXR-LBD as 
though it is ligand-bound, even in the absence of rifampicin (Table 3.1).  Additional 
measurements were carried out with 5 mM TCEP or F-SRC-1 with 30% labeling, as 
opposed to 2 mM TCEP and 10% labeling for all other curves (Table 3.1).  Equilibrium 
constants obtained at 5 mM TCEP were within error of the Kd values obtained at 2 mM 
TCEP (10% labeling).  This result indicates that 2 mM TCEP was sufficient to prevent 
significant dimerization of unlabeled SRC-1 molecules via the formation of disulfide 
bonds, as well as to maintain cysteine residues in PXR-LBD in their reduced state, as 
they would be in vivo.  Equilibrium constants obtained using F-SRC-1 with 30% labeling 
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were within error of those obtained using co-activator with 10% labeling (2 mM TCEP), 
indicating that the fluorescein tag does not significantly interfere with PXR-LBD/SRC-1 
binding. 
Table 3.1:  F-SRC-1/PXR-LBD Equilibrium Dissociation Constants Measured by 
Steady-State TIRFM. 
 
PXR-LBD [Rifampicin], μM K
d
, μM 
WT 0 4 ± 2 
WT 0.1 5 ± 3 
WT 1 4 ± 2 
WT 10 5 ± 3 
WT 100 4 ± 3 
S247W/C284W 0 4 ± 2 
WT / S247W/C284W (5 mM TCEP) 0 4 ± 2 
WT (30% labeled F-SRC-1) 0 5 ± 2 
 
Reported Kd values are averages of values obtained from two binding isotherms.  Controls were 
carried out with a ligand-bound mimic of the receptor, PXR-LBD (S247W/C284W); 5 mM 
TCEP, as opposed to 2 mM; and F-SRC-1 with 30% labeling, instead of 10%.  For the 5 mM 
TCEP control, one curve was measured for wild type PXR-LBD and the other for the double 
tryptophan mutant.  Uncertainties are propagated from the errors associated with each of the two 
fits.  WT PXR-LBD refers to AviTag-His6-PXR-LBD (130-434) fusion protein, with no other 
modifications. 
 
 The density, S, of PXR-LBD at the surface was experimentally determined by 
using the best fit values of QS (the saturating fluorescence in the binding isotherm) and 
Qd (the slope of the background), and an estimated value of d ≈ 85 nm for our system 
(33).  The density of PXR-LBD at the surface served as an internal control, as the values 
of S should be on the same order of magnitude for all binding curves and within error of 
each other for measurements conducted with a single batch of PXR.  The densities ranged 
from 1 – 7 x 103 molecules/μm2, with an average of 4 ± 2 x 103 molecules/μm2.  For 
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measurements carried out using the same batch of PXR, the S values, as returned by the 
fitting program, were always within error of each other. 
3.5.3 F-SRC-1/PXR-LBD Dissociation Rate Constants Measured by TIR-FRAP 
TIR-FRAP was employed to examine the kinetics of the interaction between F-
SRC-1 and PXR-LBD at 0, 10 and 100 μM rifampicin.  In conducting these 
measurements, the surface-associated fluorescence generated by TIR illumination was 
monitored before and after a short, intense bleach pulse.  Once an evanescently 
illuminated area is photobleached, the fluorescence recovers as surface-bound, 
photobleached molecules dissociate and are replaced by unbleached molecules in 
solution.  The rate of this recovery reflects the rate at which photobleached molecules 
dissociate from surface binding sites (22, 29).  In the absence of surface rebinding, the 
temporal shape of the recovery curve is predicted to be a single exponential with a rate 
equal to the intrinsic off-rate (34). 
Figure 3.4 shows two representative fluorescence recovery curves for 1.25 μM 
(Fig. 3.4A) and 20 μM (Fig. 3.4B) F-SRC-1 interacting with PXR-LBD in the absence of 
rifampicin.  The curves were obtained using a 300 mW, 50 ms bleach pulse, and 
fluorescence was measured for 30 s after photobleaching.  As shown, fluorescence 
recovery was rapid and essentially complete after 30 s. 
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Figure 3.4:  Representative Fluorescence Recovery Curves.  These plots show typical 
fluorescence recovery curves for (A) 1.25 μM and (B) 20 μM F-SRC-1 interacting with PXR-
LBD in the absence of ligand, obtained using a 300 mW, 50 ms bleach pulse.  Fluorescence 
values have been normalized to average pre-bleach fluorescence values and then fit to one- (green 
curves; f2 = 0 in Eq. 3.2) and two- (red curves; f2 ≠ 0 in Eq. 3.2) exponential models.  It is evident, 
especially at the early recovery times, that the two-exponential model is a better fit for the data.  
All reported values are derived from two-exponential fits.  For the curves shown here the values 
of f1, k1, f2, k2 and µ were (A) 8.0 ± 0.4 kHz, 0.76 ± 0.08 s
-1
, 4.3 ± 0.4 kHz, 0.126 ± 0.012 s
-1
 and 
0.88,  respectively, and (B) 15.0 ± 0.8 kHz, 1.56 ± 0.13 s
-1
, 2.5 ± 0.3 kHz, 0.15 ± 0.02 s
-1
 and 
0.83, respectively.  The weighted average of the two rate constants, koff, was (A) 0.54 s
-1
 and (B) 
1.36 s
-1
. 
 
To confirm that F-SRC-1 was indeed highly reversibly interacting with 
immobilized PXR-LBD, the surface associated fluorescence was measured following the 
application of F-SRC-1 and immediately after washing with 2 mL of Buffer D.  The 
surface associated fluorescence was at background levels after washing, indicating that F-
SRC-1 was completely washed away and interacts only reversibly with PXR-LBD.  This 
observation also informs one that the larger fragment of SRC-1, with which PXR-LBD is 
co-expressed, is most likely removed during the washing step following the application 
of PXR-LBD to the substrate, if not before during PXR-LBD purification (as indicated by 
gel electrophoresis, see Materials and Methods). 
In a system such as ours where F-SRC-1 reversibly interacts with surface-bound 
PXR-LBD, one would at first expect a single intrinsic dissociation rate constant.  Hence, 
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fluorescence recovery curves were expected to be monoexponential, with the single 
exponent reflecting the one rate constant.  However, as illustrated in Figure 3.4 and as 
previously observed for a variety of other systems (19, 22, 29), the curves are not 
monoexponential, but are in fact better described by the sum of two exponentials,  
     tktk efefftf 21 11 210   ,       (3.2) 
where f0 is the fluorescence at time zero, defined as the center of the bleach pulse.  The 
weighted average of the two exponential factors, k1 and k2, can be used to determine an 
average off-rate, as follows: 
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The fractions of the pre-bleach fluorescence, fp, that were bleached (β) and then 
recovered (µ) were calculated as follows: 
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In the TIR-FRAP measurements, the monitoring excitation intensity was low 
enough so that in the absence of a bleach pulse, the evanescently excited fluorescence 
was constant with no measurable decrease during the typical post-bleach monitoring time 
of 30 s.  Potential photo-induced artifacts arising from the intense photobleaching pulse 
were ruled out by three different types of control measurements.  Here, quantitative 
analysis of recovery curves indicated no significant difference in the best-fit values of koff 
for (a) a three-fold increase in the bleaching intensity; (b) a two-fold increase in the 
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bleaching time; or (c) recovery curves obtained following sequential bleaching of 
identical regions after previous fluorescence recovery. 
TIR-FRAP recovery curves were obtained for a range of F-SRC-1 concentrations, 
at the three different rifampicin concentrations.  As shown in Figure 3.5, fluorescence 
recovery was significantly slower at lower F-SRC-1 concentrations.  This observation is 
almost certainly due to the fact that at lower F-SRC-1 concentrations there is an increased 
density of free PXR-LBD on the surface.  Consequently, bleached molecules that 
dissociate from surface binding sites rebind free PXR-LBD at a higher frequency, 
reducing the overall rate of fluorescence recovery and thereby the observed rate 
constants.  The intrinsic dissociation rate constant was taken to be the value at which the 
weight-averaged off-rate, koff, was maximized and independent of the F-SRC-1 
concentration.  Towards this end, average off-rates were plotted as a function of the F-
SRC-1 concentration and fit to the model shown in Eq. 3.5 (29) to determine the limit of 
the off-rate as the F-SRC-1 concentration approached infinity, given by offk : 
 
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         (3.5) 
In Eq. 3.5, koff(A) is the measured average off-rate for a given value of A, and C is an 
arbitrary constant.  The free parameters were offk  and C.  Intrinsic, average dissociation 
rate constants, offk , were obtained for the F-SRC-1/PXR-LBD interaction at 0,10 and 
100 μM rifampicin and found to be 2.0 ± 0.1 s-1, 2.4 ± 0.3 s-1 and 2.4 ± 0.1 s-1, 
respectively (Figure 3.5A).  As with the thermodynamics, rifampicin does not affect the 
kinetics of the interaction between F-SRC-1 and PXR-LBD. 
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Figure 3.5:  F-SRC-1/PXR-LBD Dissociation Rate Constants Measured by TIR-FRAP and 
Theoretical Probabilities of Rebinding.  (A) Four to six recovery curves were measured for 
each of four (0 µM rifampicin) or three (10 and 100 µM rifampicin) independently prepared 
samples, for each F-SRC-1 concentration.  These measurements were carried out using 300 mW, 
50 ms; 200 mW, 50 ms; and 100 mW, 100 ms bleach pulses.  Each recovery curve was fit to Eq. 
3.2 and the best-fit values of f1, k1, f2, k2 were used to calculate koff according to Eq. 3.3.  The off 
rates (koff) obtained from the recovery curves pertaining to a single sample were averaged.  The 
points shown in the plot are the averages of 3-4 of these mean koff values for each F-SRC-1 and 
rifampicin concentration, with the associated standard deviation.  These values of koff as a 
function of F-SRC-1 concentration, in the absence (open circles) and presence (10 µM, closed 
circles; 100 µM, closed triangles) of rifampicin, were fit to the model in Eq. 3.5.  The best-fit 
values of the intrinsic dissociation rates, 

offk , were 2.0 ± 0.1 s
-1
, 2.4 ± 0.3 s
-1
 and 2.4 ± 0.1 s
-1 
at 
0, 10 and 100 µM rifampicin, respectively. (B) Probabilities of rebinding computed by 
numerically integrating Eq. 3.6 from t = 0 s (the center of the bleach pulse) to t = 30 s (after 
photobleaching), using Kd = 4 µM, koff = 2 s
-1
, S = 3000 molecules µm
-2
, D = 100 µm
2
 s
-1
, wx = 
22.4 µm and wy = 65.0 µm. 
 
As previously shown (35), the probability that a bleached molecule which 
dissociates from the origin at time zero has rebound at least once within the illuminated 
and observed area after the duration of the post-bleach observation is  
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where tf is the duration of the observation time after photobleaching, wx and wy are the 
1/e
2
-radii of the elliptically Gaussian illuminated area, D is diffusion coefficient of F-
SRC-1 in solution and η describes the propensity for rebinding.  The parameter η is given 
by 
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where kon is the association rate constant, obtained by computing the quotient of the 
measured dissociation rate constant and equilibrium dissociation constant.  Figure 3.5B 
shows the values of Eq. 3.6 numerically evaluated for tf = 30 s, Kd = 4 µM, koff = 2 s
-1
, S 
= 3000 molecules µm
-2
, D = 100 µm
2
 s
-1
, wx = 22.4 µm and wy = 65.0 µm.  As shown, P 
is significant at the lower F-SRC-1 concentrations but becomes negligibly small for the 
higher F-SRC-1 concentrations.  This information is consistent with the interpretation 
that the measured fluorescence recovery curves are significantly affected by surface 
rebinding at low F-SRC-1 concentrations but, that at the higher F-SRC-1 concentrations, 
the effects of surface rebinding are negligible and the recovery curves accurately report 
the intrinsic surface dissociation kinetics. 
3.5.4 SMRT/PXR-LBD Equilibrium Dissociation Constants Measured by 
Steady-State TIRFM 
SMRT/PXR-LBD equilibrium constants were obtained from competition curves 
in which SMRT was titrated against a fixed concentration of F-SRC-1 (5 µM).  Steady-
state TIRFM was used to measure the decrease in surface-associated fluorescence as 
increasing amounts of SMRT competed with a fixed concentration of F-SRC-1 to bind 
surface-bound PXR-LBD.  Competition curves were obtained at rifampicin 
concentrations of 0, 10 and 100 µM.  Background-subtracted data were fit to Eq. 3.8 to 
obtain the equilibrium dissociation constant, Kd’, for the interaction between co-repressor 
and PXR-LBD. 
   
 
   '1 dd
d
KBKA
KAQS
FF

        (3.8) 
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In Eq. 3.8 Q is a proportionality constant, S is the surface density of PXR-LBD, Kd is the 
F-SRC-1/PXR-LBD dissociation constant, A is the concentration of F-SRC-1 and B is 
the concentration of co-repressor.  QS and Kd’ were free parameters, while Kd and A 
were fixed at 5 µM.  Figure 3.6 (closed circles) shows the background-subtracted, SMRT 
competition curve obtained in the absence of ligand.  Fitting the data in Figure 3.6 to Eq. 
3.8 yielded an equilibrium dissociation constant of 65 ± 13 µM for the interaction 
between SMRT and PXR-LBD.  An equilibrium dissociation constant of 51 ± 14 µM was 
obtained at 100 µM rifampicin (see Table 3.2).  The fact that these values are within error 
of each other indicate that rifampicin does not alter the affinity of SMRT and PXR 
fragments.  Competition curves were also obtained using a peptide fragment of another 
co-repressor called the nuclear receptor co-repressor (NCoR).  NCoR, which has been 
reported to not interact with PXR (13), competed even more weakly with F-SRC-1 to 
bind surface-bound PXR-LBD (see Figure 3.6; open circles).  Fitting these data to Eq. 3.8 
yielded an equilibrium constant of 200 ± 50 µM for the NCoR/PXR-LBD interaction in 
the absence of ligand.  This value was within error of those obtained at 10 and 100 µM 
rifampicin as shown in Table 3.2. 
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Figure 3.6:  Representative Co-repressor Competition Data.  This plot shows the background-
subtracted and normalized fluorescence as a function of SMRT (closed circles) and NCoR (open 
circles) concentrations obtained at 5 µM F-SRC-1, in the absence of ligand.  Background 
fluorescence, measured in the absence of surface-immobilized PXR-LBD, was subtracted and the 
data were fit to Eq. 3.8 with QS and Kd’ as free parameters and using the fixed parameters, A = 5 
µM and Kd = 5 µM.  Equilibrium dissociation constants of 65 ± 13 µM and 200 ± 50 µM were 
obtained for the SMRT/PXR-LBD (closed circles) and NCoR/PXR-LBD (open circles) 
interactions, respectively.  The above data were normalized to fluorescence counts determined 
using the fit parameter QS, A = 5 µM, Kd = 5 µM and B = 0 µM (no co-repressor).  The data are 
averages of two trials and the errors are the corresponding standard deviations. 
 
 
Table 3.2:  Co-repressor/PXR-LBD Equilibrium Dissociation Constants Measured 
by Steady-State TIRFM. 
 
[Rifampicin], 
μM 
K
d
’, μM 
SMRT NCoR 
0 65 ± 13 200 ± 50 
10 82 ± 11 160 ± 40 
100 51 ± 14 160 ± 40 
 
Reported Kd’ values are averages obtained from two competition curves.  Uncertainties are 
propagated from the errors associated with each of the two fits. 
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3.6 Discussion 
 The nuclear receptor PXR plays an important role in the metabolism of endobiotic 
and xenobiotic compounds, including many pharmaceutical products, by regulating the 
expression of drug-metabolizing enzymes.  The conventional view of nuclear receptor 
action is that upon binding agonists, nuclear receptors preferentially associate with co-
activators, which in turn recruit downstream members of the transcription machinery 
(36).  In the present study, we investigated the interaction between the ligand binding 
domain of PXR and a relevant peptide derived from the co-activator, SRC-1, in the 
presence and absence of the PXR agonist, rifampicin.  Specifically, TIRFM and TIR-
FRAP were employed to examine the thermodynamics and kinetics of PXR-LBD 
interacting with a fluorescently labeled SRC-1 peptide at different rifampicin 
concentrations.  The equilibrium and dissociation rate constants for the PXR-LBD/F-
SRC-1 interaction were unchanged in the presence of rifampicin.  In the absence of 
ligand, the basal transcriptional activity of PXR was reported to be significantly reduced 
by the co-repressor SMRT (13).  Thus, the thermodynamics of the interaction between 
PXR-LBD and a peptide fragment of SMRT was also measured using TIRFM.  Again, 
rifampicin had no effect on the PXR-LBD/SMRT interaction.  These results indicate that 
the agonist rifampicin does not affect PXR’s affinity for (at least these two) co-regulators. 
 While no known rigorous biophysical studies have been previously conducted to 
quantitatively characterize the interaction between PXR, co-activators and ligands, the 
thermodynamics and kinetics of other nuclear receptors, particularly the steroid hormone 
receptors, interacting with co-regulators and ligands have been measured.  As reported 
above, apparent equilibrium and dissociation rate constants of 5 µM and 2 s
-1
, 
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respectively, were obtained for the interaction between PXR-LBD and SRC-1 (676 – 
700) both in the presence and absence of rifampicin.  This measured apparent equilibrium 
dissociation constant is at the weak end of the spectrum of affinities measured for nuclear 
receptors, many of which fall in the nanomolar range.  Fluorescence polarization assays 
of full length SRC-1 interacting with the full length estrogen receptor (ER) and ER-LBD 
in the presence of estrogen yielded a Kd of ~ 30 nM on both occasions (37).  In the 
absence of ligand, no interaction was observed.  Equilibrium constants of full length ER 
and another member of the steroid receptor co-activator family, SRC-2, interacting in live 
cells have been estimated using fluorescence cross-correlation spectroscopy.  Estimated 
Kd values of ~200 nM, < 6 nM and > 3 µM were obtained for ER/SRC-2 in the apo-, 
agonist-bound and antagonist-bound states, respectively (38).  Equilibrium constants of 
~160 nM were obtained for the thyroid receptor LBD interacting with a SRC-2 fragment 
in the presence of thyroxin (39, 40).  Surface plasmon resonance yielded an apparent 
dissociation rate constant on the order of 1 x 10
-2
 s
-1
 for this interaction (40).  However, a 
recent study showed that the glucocorticoid receptor (GR), like PXR, binds many co-
regulator peptides with micromolar affinity in the presence of the GR agonist, 
dexamethasone (41).  Further studies have shown that another receptor, the peroxisome 
proliferator-activated receptor-γ (PPARγ), is able to bind SRC-1 in the absence of ligand 
with an equilibrium dissociation constant of 34.2 µM (42).  Addition of a ligand did 
increase the affinity of PPARγ and SRC-1, and a Kd of 0.96 µM was obtained.  The 
ability of both PXR and PPARγ to bind co-activators in the absence of ligand may 
account for their relatively high level of basal activity.  FRET measurements have been 
used to look at the interaction between full length, human PXR and the same 25 amino 
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acid fragment of SRC-1 used in the present study, as a function of the rifampicin 
concentration (43).  While the assay did not yield equilibrium dissociation constants for 
PXR and SRC-1, it did show, contrary to our findings, that rifampicin slightly, but within 
experimental uncertainty, increased co-activator recruitment.  We cannot yet account for 
this discrepancy. 
The structures of LBDs are conserved among the various members of the nuclear 
receptor superfamily (44, 45).  Briefly, nuclear receptor LBDs consist of approximately 
twelve α-helices arranged into three layers and two to five β-strands that line a side of the 
ligand binding pocket.  The ligand binding pocket exists as a cavity on one side of the 
LBD and is lined primarily by hydrophobic residues from several α-helices and β-strands.  
The co-activator binding site consists of a hydrophobic groove on the surface of the LBD, 
created by α helices 3, 4 and 12 in PXR. 
Crystal structures of nuclear receptors in the apo- and agonist- bound states have 
contributed to an existing molecular model of ligand-mediated interaction between 
nuclear receptors and co-activators.  A crystal structure of the retinoid acid receptor in the 
apo-state showed helix 12 (H12), or activation function-2 (AF-2), extended away from 
the main body of the LBD (9), whereas subsequent structures of ligand-bound nuclear 
receptor LBDs showed H12 folded against the body of the LBD (10, 11).  In this folded 
conformation, LBDs can bind conserved LXXLL motifs in co-activators via a charge 
clamp (11).  Therefore, it is thought that H12 serves as the molecular switch that is 
modulated by ligands to promote nuclear receptor interaction with co-activators.  PXR-
LBD was co-crystallized with the same 25 amino acid fragment of SRC-1 (residues 676-
700) used in this study, and the agonist SR12813 (12).  The SRC-1 fragment formed a 
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kinked α-helix and bound to a groove on the surface of PXR-LBD created by helices H3, 
H4 and H12.  Two polar contacts between PXR-LBD and SRC-1 [K259 (H3): carbonyl 
oxygen L694; E427 (H12): amine nitrogen I689] constituted the charge clamp that has 
also been observed in other nuclear receptor/co-activator complexes.  In addition, a 
hydrogen bond was formed between K227 (H4) and H687.  This lysine residue is also 
conserved in other nuclear receptors, including the constitutive androstane, liver X, 
farnesoid X and vitamin D receptors. 
Crystal structures of ligand-bound nuclear receptors have helped elucidate the 
manner in which many endogenous ligands stabilize H12 in the folded or active 
conformation.  It appears that a canonical π-cation interaction stabilizes H12 in the folded 
state in the steroid hormone receptors (46), which encompass the glucocorticoid, 
mineralcorticoid, progesterone, androgen and estrogen receptors, as well as in other 
nuclear receptors, including the vitamin D, thyroid hormone, farnesoid X and liver X 
receptors (47).  In the non-steroid hormone receptors, an oxygen atom from each 
receptor’s endogenous ligand forms an electrostatic interaction with a conserved histidine 
in H10 or H11, which in turn makes π-cation interactions with a conserved tryptophan or 
phenylalanine in H12.  In this way, ligands of many nuclear receptors indirectly stabilize 
H12 in the active conformation.  However, it is not immediately clear from crystal 
structures of ligand-bound PXR-LBD how agonists might stabilize PXR’s H12 in the 
folded state.  PXR ligands are structurally diverse and appear to lack a common chemical 
feature that could stabilize the active conformation.  Furthermore, attempts to design an 
antagonist directed at the PXR ligand binding pocket have thus far failed, with many of 
the proposed compounds instead serving as agonists (48).  It appears that any compound 
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that binds PXR’s ligand binding pocket serves to activate the receptor.  (Compounds that 
antagonize PXR by competing with co-activators to bind the receptor have been 
described (27, 31).)  Therefore, it is likely that PXR ligands do not directly stabilize the 
active conformation and increase the receptors’s affinity for co-activators, but instead 
work through an alternate mechanism to upregulate PXR activity. 
A crystal structure of apo-PXR-LBD shows H12 in the active conformation, 
indicating that the folded state may be favored even in the absence of ligand (25).  If the 
active conformation is energetically favored in the apo-state, that fact could explain our 
observation that PXR-LBD interacts with the SRC-1 fragment in a ligand-independent 
manner.  Furthermore, PXR has a high level of basal activity relative to other nuclear 
receptors (49), indicating that the receptor maybe able to adopt a stable active 
conformation in the absence of ligand.  In support of this conclusion, molecular dynamics 
simulations on PXR have shown that the AF-2 region of the receptor moves as a 
correlated unit in the absence of ligands (50). 
PXR is somewhat unique because it binds promiscuously to structurally diverse 
ligands.  In fact, ligands that range in molecular weight from 232 (phenobarbitol) to 823 
(rifampicin) have been shown to activate PXR.  A 60 amino acid insert found in PXR-
LBD that serves to create a 5-stranded β sheet lining one side of the ligand binding 
pocket, as opposed to the 2- or 3-stranded β sheet seen in other nuclear receptors, is 
thought to contribute to a large, flexible ligand binding pocket that enables PXR to 
accommodate diverse ligands (25).  The ligand binding pocket can range in volume from 
1150 Å
3
 in the apo-state (25) to ~1900 Å
3
 with rifampicin bound (7).  Such a large cavity 
in the body of this globular protein may serve to destabilize apo-PXR.  Ligand binding 
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may increase the stability of PXR and thereby its lifetime in vivo.  Ligand-dependent 
activation of PXR might then be a consequence of the increased stability of ligand-bound 
receptor. 
Nonetheless, studies of the interaction between PXR and SRC-1 in cells suggest 
that the interaction is enhanced in the presence of ligands.  In vitro co-precipitation 
assays of bacterially expressed GST-tagged PXR-LBD and a [
35
S]-labeled SRC-1 
fragment, containing the co-activator’s receptor interaction domain (RID), showed a 
weakly enhanced interaction in the presence of various agonists, including rifampicin (5, 
51).  It is worth noting that the corresponding interaction between a GST-tagged LBD of 
the estrogen receptor (ER) and radio-labeled SRC-1-RID was much more greatly 
enhanced in the presence of estradiol (51).  Mammalian two-hybrid assays have also 
demonstrated a ligand-dependent interaction for SRC-1-RID and PXR, with similar 
results being obtained for both full length PXR and PXR-LBD (31, 52).  Indeed these 
studies were conducted with SRC-1-RID, which contains three LXXLL motifs, as 
opposed to the 25 amino acid fragment used in this study, which only has one LXXLL 
motif, albeit the most strongly interacting one (53).  However, yeast two-hybrid assays 
have shown that co-activator fragments as small as eight amino acids, containing a single 
LXXLL motif, are able to interact with ER-LBD in a ligand-dependent manner (54).  
Therefore, it is unlikely that our observation that the interaction between PXR-LBD and 
the SRC-1 fragment is rifampicin-independent is due to the use of a 25 amino acid 
fragment of SRC-1, as opposed to the use of a larger fragment or the full length protein 
which is 1441 residues long.  It is possible that the observed ligand-dependence in the in 
vivo biochemical assays is due to an increased stability of ligand-bound PXR. 
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Thermal denaturation studies using circular dichroism spectropolarimetry have 
shown that ligands do stabilize PXR-LBD.  Melting temperatures of 43.0 ± 0.08 (12), 
48.4 ± 0.05 (12) and 46.5 ± 0.05 ⁰C (55) were obtained for apo-, SR12813-bound and 
rifampicin-bound PXR-LBD, respectively.  A complex of SRC-1 and PXR-LBD had a 
melting temperature of 48.2 ± 0.08 ⁰C (12).  These results show that agonists and co-
activator each serve to stabilize PXR-LBD.  Ternary complexes of PXR-LBD and SRC-1 
with either SR12813 or rifampicin were even more stable with melting temperatures of 
52.5 ± 0.05 (12) and 52.6 ± 0.03 ⁰C, respectively.  One might expect that this increase in 
stability upon addition of the third component would mean that the agonist and co-
activator bind co-operatively, resulting in a ligand-dependent increase in affinity for the 
co-activator and vice versa.  However, if the increased thermal stability is due to 
rifampicin and SRC-1 independently stabilizing different regions of PXR-LBD, binding 
of one may not increase the receptor’s affinity for the other. 
Another possibility is that ligand-dependent activation of PXR occurs through a 
novel pathway that is as yet uncharacterized.  A recent study demonstrated that the 
nuclear receptor peroxisome proliferator-activated receptor-γ (PPARγ) is activated by 
structurally diverse serotonin and fatty acid metabolites (42).  PPARγ, like PXR, has a 
flexible ligand binding pocket that can accommodate many different endogenous and 
exogenous ligands.  Crystal structures of PPARγ in complex with a mimic of serotonin 
metabolites, indomethacin (IDM), showed that it bound in a distinct region of the ligand 
binding pocket and made direct contact with H12, securing the helix in the active 
conformation.  However, fatty acid metabolites bound away from H12 and failed to make 
any contact with the helix.  Surface plasmon resonance studies showed IDM induced 
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PPARγ to recruit SRC-1.  In fact, equilibrium dissociation constants of 34.2 µM and 0.96 
µM were obtained for PPARγ and SRC-1 in the absence and presence of IDM, 
respectively.  While IDM brought about a thirty-fold increase in the affinity of PPARγ 
for SRC-1, the fatty acid metabolite, nitro-233, failed to enhance the interaction between 
the receptor and co-activator.  Instead, it was proposed that nitro-233 may modulate 
heterodimerization with the retinoid X receptor.  Given the structural diversity of PXR 
ligands, agonists like rifampicin may very well use different pathways to activate PXR. 
Another aspect related to nuclear receptor function is the previous observation 
that many receptors have the capability of forming homodimers or heterodimers with 
other nuclear receptors.  In the case of PXR, the physiologically relevant receptor dimer 
is thought to be one with RXR.  Nonetheless, a previous work has shown that PXR-LBD 
homodimerizes in vitro with an equilibrium dissociation constant of 4.5 µM (26).  A 
dimerization-null mutant was found to be incapable of binding SRC-1 peptide either in 
the presence or absence of ligand.  However, this result is not completely consistent with 
a separate report in which ligand-dependent SRC-1 peptide interaction with PXR-LBD 
was observed in vitro for a receptor concentration of 20 nM (43), well below the Kd for 
dimerization where one would predict that the PXR-LBD was present almost exclusively 
in monomeric form.  One possibility is that the discrepancy arises in an indirect manner 
as a consequence of the mutations introduced to form the dimerization-null PXR-LBD.  
Independent of these results, it is important to address the question of the state of 
dimerization of the PXR-LBD used in the work reported herein.  The solution 
concentration before application to the surface was 0.1 mg/mL = 2.6 µM; thus, the 
previously measured dimerization Kd would imply that the solutions contained primarily 
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monomeric PXR-LBD with a non-negligible fraction of dimeric PXR-LBD.  It is not 
possible to determine, after application to the surfaces and washing, what fraction of the 
immobilized PXR-LBD was in monomeric or dimeric form.  Nonetheless, the results 
show clearly that the SRC-1 peptide does specifically and reversibly interact with at least 
a fraction of the immobilized PXR-LBD.  Definitive conclusions about the interaction of 
SRC-1 peptides with monomeric and dimeric forms of PXR-LBD await further 
measurements. 
 The interaction between co-repressors and nuclear receptors, particularly PXR, 
has not been as extensively studied as that between co-activators and nuclear receptors.  
Certainly, the authors are unaware of any biophysical studies of PXR and its co-
repressors.  Instead, cell-based assays have been used to show that the SMRT-RID 
specifically interacts with PXR, while that of NCoR does not (13).  Hence, the present 
finding that the peptide derived from SMRT binds PXR-LBD with greater affinity (Kd’ = 
~ 70 µM) than the NCoR fragment (Kd’ = ~ 170 µM), is consistent with what has been 
reported in the literature.  Only one of two interaction domains (LXXXIXXXL; ID1 and 
ID2), ID2, in the SMRT-RID was shown to actually bind PXR (14).  In addition, of the 
two major SMRT splicing isoforms, α and τ, ID2 derived from SMRTα was found to 
bind preferentially to PXR (15).  Compared to SMRTτ, SMRTα contains a 46 amino acid 
insert immediately downstream of ID2.  For the purposes of the present study, a peptide 
containing ID2 from SMRTα was used.  Reporter assays showed that SMRT (α and τ) 
reduces both the basal and rifampicin-induced transcriptional activity of PXR on the 
CYP3A4 promoter (13, 14).  These results indicate that SMRT is able to compete with 
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co-activators to bind PXR both in the absence and presence of ligand, and thereby reduce 
the receptor’s transcriptional activity. 
In addition to the fact that SMRTα binds preferentially to PXR, it has been shown 
that SMRTα resists rifampicin-induced dissociation from PXR (15), while SMRTτ does 
not (14).  These results are consistent with our observation that the co-repressor peptide 
derived from SMRTα binds PXR-LBD with equal affinity both in the presence and 
absence of rifampicin.  However, the measured equilibrium dissociation constant of 
SMRTα (2337-2358) and PXR-LBD, which averages to ~ 70 µM over the three 
rifampicin concentrations (see Table 3.2), is quite weak.  In comparison, fluorescence 
polarization measurements of the thyroid hormone receptor-β LBD and SMRTα (2329-
2358) yielded equilibrium dissociation constants of ~ 1 µM (16).  It is unclear whether a 
larger fragment of SMRTα would have interacted with PXR-LBD with greater affinity.  
However, if the measured equilibrium constant is accurate, the interaction between 
SMRTα and PXR-LBD may not be physiologically relevant.  It is possible that there are 
other co-repressors that interact with PXR with higher affinity and in a ligand-dependent 
manner. 
Crystal structures of nuclear receptor LBDs and peptide fragments of SMRT have 
revealed the mode of co-repressor binding, and thereby elucidated the reason for the 
competition between co-repressors and co-activators to bind nuclear receptors.  A crystal 
structure of a PPAR isoform, PPARα, LBD in complex with an antagonist, GW490544, 
and the same peptide fragment of SMRTα (2337-2358) that was used in the present work, 
showed that the co-repressor bound to a hydrophobic groove on the surface of the LBD 
that overlapped with the co-activator binding site (16).  GW490544, like many nuclear 
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receptor antagonists, had a portion that protruded out from the ligand binding pocket and 
prevented H12 (AF-2) from assuming its active conformation.  This repositioning of H12 
allowed the co-repressor peptide to bind a groove formed by H3, H3’, H4 and H5.  In the 
ternary complex, SMRT adopted a three-turn α-helix, unlike the two-turn α-helix formed 
by SRC-1.  The additional helical turn in SMRT extended into the space that is normally 
occupied by H12 in the active conformation.  The co-repressor/PPAR-α complex was 
stabilized by polar contacts between the backbone carbonyls of A2348 and L2349 and the 
amine nitrogen of the same, conserved lysine residue in H3 that helps form the charge 
clamp with co-activators.  Since the co-activator and co-repressor binding-sites overlap 
so greatly, one of these co-regulators binding a nuclear receptor would necessarily 
prevent the other from binding.  In the apo-state, when H12 is allowed to freely sample 
active and inactive conformations, one would expect co-activators and co-repressors to 
compete with each other to bind nuclear receptors.  If in fact rifampicin fails to secure 
H12 in the active conformation, as is implied by existing structural data and the present 
thermodynamic and kinetic data for SRC-1/PXR-LBD interactions, one would expect, as 
observed, that rifampicin does not affect the ability of co-repressors to bind PXR-LBD. 
 The present thermodynamic and kinetic measurements indicate that rifampicin 
does not increase the affinity of PXR-LBD for the SRC-1 fragment, or decrease the 
receptor’s affinity for SMRT.  The vast structural diversity of PXR ligands makes it 
unlikely that all agonists would be able to form direct or indirect interactions with 
residues in H12, as seen with the π-cation interactions, to stabilize the active 
conformation.  It is possible that the different PXR ligands work through an alternate 
mechanism, or even several mechanisms like in the case with PPARγ, to activate the 
104 
 
receptor.  One such possibility is that ligands, by filling the large cavity that is the ligand 
binding pocket, confer stability to PXR and increase the receptor’s in vivo lifetime.  Other 
plausible ligand-dependent regulatory mechanisms include an interplay between 
(physiologically relevant) co-repressors and co-activators, homodimerization or 
heterodimerization with RXR, phosphorylation, and the differential affinity of PXR for 
various chaperone proteins in the ligand-bound versus apo- states.  These possible 
mechanisms of action are all avenues for future study. 
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Chapter 4 
 
FcγRII and IgG Interactions: A Test System for TIR-FCS 
 
4.1 Introduction 
Total internal reflection fluorescence microscopy combined with fluorescence 
correlation spectroscopy (TIR-FCS) is a novel technique that provides quantitative 
information about the behavior of fluorescent molecules at or near the interface between 
a solid transparent substrate and aqueous medium (1).  In an application of the technique, 
TIR-FCS was used to examine the reversible association of a fluorescent species with 
surface-immobilized receptors.  Specifically, the kinetic parameters of fluorescently 
labeled mouse antibodies (IgG) interacting with Fc receptors (FcγRII) reconstituted in 
supported planar bilayers were measured using TIR-FCS (2).  When conducting these 
measurements, Lieto et al. (2) used low concentrations (~10 nM) of the fluorescent 
antibody (F-IgG) to obtain fluorescence fluctuations that were sufficiently large to be 
accurately measured.  However, 10 nM F-IgG is far below the midpoint (~1 µM) of the 
IgG/FcγRII binding isotherm.  To avoid possible rare, tight, nonspecific binding events, 
the effects of which could be unduly prominent at such low concentrations, F-IgG was 
mixed with unlabeled IgG to a final concentration of 1 µM.  In deriving a general TIR-
FCS expression to describe such a system (one in which fluorescent and nonfluorescent 
ligands compete to bind surface-bound receptors), Lieto and Thompson (3) showed that 
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at long correlation-lag times, τ, TIR-FCS curves, in theory, contain kinetic information 
about the nonfluorescent species. 
 As in Chapter 2, we sought to determine experimental conditions that might yield 
autocorrelation curves containing significant kinetic information about both the 
fluorescent ligand and a nonfluorescent competitor that is distinct from the labeled 
ligand.  To test these conditions, we set out to establish a model system consisting of an 
IgG, immobilized via its antigen binding site to a supported planar bilayer, a 
fluorescently labeled, soluble, extracellular portion of FcγRII (F-sFcγRII) and a peptide 
derived from the IgG binding site on FcγRII that would serve as the nonfluorescent 
competitor.  As mentioned in the previous Chapter, the pregnane X receptor and its 
interacting partners, which were initially meant to serve as a test system for the 
nonfluorescent effector theory, turned out to be well suited for the testing of the 
nonfluorescent competitor theory.  Nevertheless, the soluble FcγRII and IgG can still be 
used to test the experimental conditions detailed in Chapter 2 that were predicted to yield 
autocorrelation curves containing significant information about the thermodynamic and 
kinetic parameters pertaining to the interaction between a single, fluorescent ligand and 
surface-bound receptor. 
4.1.1 Theoretical Background 
Lieto and Thompson (3) showed that, theoretically, TIR-FCS can be used to 
detect the cross-talk between fluorescent and nonfluorescent species as they compete for 
surface binding sites.  In our system, nonfluorescent competitors, Lc, compete with 
fluorescently labeled reporter-ligands, Lf, to reversibly bind immobile surface binding 
sites, B, as shown below. 
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Lieto and Thompson (3) derived a general expression for G(τ) in terms of the rate 
of diffusion of the fluorescent ligand through the evanescent wave, and the association 
and dissociation rate constants of both the fluorescent reporter-ligand and nonfluorescent 
competitor.  When the rate of diffusion through the evanescent field is much larger than 
the surface association and dissociation rate constants, as is often the case, the 
autocorrelation function separates into two components: 
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where Ga(τ) pertains to fluorescence fluctuations due to diffusion through the evanescent 
field, and Gs(τ) contains information about the surface association and dissociation 
kinetics (3).  Ga(τ) is given by 
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with  ff LKX 1  and  cc LKX 2 .  Rz is the rate of diffusion of the fluorescent 
reporter-ligand through the evanescent field: Rz = Df /d
2
.  Df is the diffusion constant of 
the fluorescent ligand, d is the depth of the evanescent field and h is the radius of the 
114 
 
observed area in the sample plane as defined by the pin hole.  S is the total density of 
surface binding sites. 
At the reaction limit (3-5) when the likelihood of rebinding to the surface after 
dissociation is low (6), we find that 
     21 210   esesGG ss ,       4.5 
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The amplitudes, s1 and s2, and the rates, λ1 and λ2, are a function of the solution 
concentration and surface association and dissociation rate constants of fluorescent and 
nonfluorescent molecules.  The amplitudes are given by 
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Eqs. 4.5-4.11 show that the relationship between the autocorrelation function and 
equilibrium and rate constants is quite complex.  It is not readily apparent what 
experimental conditions will yield data that also contain information about 
nonfluorescent competitors.  By taking into consideration this relationship and the limits 
of detection and sensitivity of our technique, criteria were defined that, if satisfied, should 
yield autocorrelation curves containing significant information about the thermodynamics 
and kinetics of nonfluorescent competitors.  We continue to explore the experimental 
conditions that allow us to meet these criteria by determining the range of permissible 
concentrations (of ligand), densities (of surface binding sites) and characteristic rates. 
The magnitude of the autocorrelation function at τ = 0, Gs(0), is inversely related 
to the average number of fluorescent molecules in the observed volume.  To obtain 
autocorrelation functions with magnitudes large enough to be accurately measured, the 
average number of fluorescent molecules in the observed volume has to be small.  We 
think that Gs(0) > 0.05 is an appropriate limit that will allow for the acquisition of 
accurate measurements.  Additionally, Gs(0) will have to be sufficiently large compared 
to Ga(0) to ensure that fluorescence fluctuations due to surface binding kinetics make a 
significant contribution to the observed FCS curves. 
The general expressions for G(τ) and Gs(τ), as published by Lieto and Thompson 
(3), contain w-functions and the roots of a fourth order polynomial.  At the reaction limit, 
Gs(τ) condenses to a much simpler sum of exponentials as seen in 4.5.  For most 
conditions we have examined thus far, the probability that a fluorescent ligand rebinds to 
a surface binding site within the observed area is very low.  However, if rebinding does 
present a problem, we can ensure the system approaches the reaction limit by minimizing 
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the density of surface binding sites.  We can alternatively increase the concentration of 
reporter-ligand and/or competitor so as to decrease the density of free binding sites. 
The fluorescence fluctuations due to association and dissociation kinetics will 
have to be sufficiently fast to allow for the measurement of Gs(τ).  Typically, TIR-FCS 
can only be used to study systems with characteristic times of 10 s or less.  To ensure that 
Gs(τ) has significant information about k-2, we initially defined conditions for which 
either λ1 differs from k-1 by a factor of 2 and s1 > 0.5, or λ2 differs from k-1 by a factor of 
2 and s2 > 0.5 (see below). 
4.1.2 Model System 
Fc receptors modulate immune responses by binding antibodies through their Fc 
regions and signaling to downstream effectors.  In mice, there are four known Fc 
receptors that recognize the IgG class of antibodies: FcγRI, FcγRII, FcγRIII and FcγRIV 
(7).  FcγRI is a high affinity receptor that displays nanomolar affinity for its target 
antibody, IgG2a.  The remaining Fcγ receptors display moderate affinity (1-10 µM) for a 
broader spectrum of antibodies. 
FcγRII is expressed in many cells types, including dendritic cells, macrophages 
and B- and T-lymphocytes.  It induces endocytosis and phagocytosis when crosslinked by 
antigen-bound antibody (immune) complexes.  Mutations in the human homologue of 
FcγRII can give rise to autoimmune diseases like systemic lupus erythematosus (8, 9).  
Hence, FcγRII is a potential therapeutic target, and of immense interest to the medical 
community. 
FcγRII consists of two extracellular immunoglobulin domains (designated D1 and 
D2 in Figure 4.1), a single transmembrane helix and an intracellular region that signals 
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downstream.  Crystal structures of the extracellular region of several human Fcγ 
receptors have been solved, both alone and in complex with the Fc regions of IgG (10-
12).  The crystal structure of human FcγRIIIA in complex with IgG1 Fc region suggests 
that an antibody can only bind one Fcγ receptor (12).  Mutagenesis studies and crystal 
structures show that only one of the immunoglobulin domains (D2 in FcγRII) binds IgGs 
(13-15).  These findings suggest that the stoichiometry of FcγRII-IgG binding is 1:1.  
Hence, the theoretical autocorrelation function also assumes 1:1 binding. 
 
Figure 4.1:  Structure of IgG1 and extracellular region of FcγRII.  (a) IgG are composed of 
two light and heavy chains.  The lights chains fold into a variable domain (V
L
) and a constant 
domain (C
L
).  In IgG1, the heavy chains fold into one variable domain (V
H
) and three constant 
domains (Cγ).  (b) Extracellular region of FcγRII consisting of two immunoglobulin domains, D1 
and D2.  The IgG binding site on FcγRII has been mapped onto loops B/C, C’/E and F/G on D2.  
X-crystal-structure obtained from the Protein Data Bank (PDB entry 2fbs).  The three loops bind 
the hinge region between Cγ1 and Cγ2 on IgG. 
 
As mentioned above, TIR-FCS has been employed to measure the kinetic 
parameters of mouse IgG reversibly interacting with membrane-bound FcγRII (2).  These 
measurements (Kd = ~1 μM; kon = ~1 μM
-1
s
-1
; koff = ~1 s
-1
) are consistent with those 
obtained by other methods (16-18).  To see whether these values would change with 
membrane-bound antibodies, complementary experiments were conducted where IgG 
was immobilized on supported planar bilayers and the soluble, extracellular region of 
FcγRII (sFcγRII) served as the fluorescently labeled ligand (19).  TIRFM and TIR-FPR 
a b 
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(fluorescence photobleaching recovery) measurements showed that the thermodynamic 
and kinetic parameters did not change when the antibodies were immobilized on a planar 
substrate.  In the present work, an experimental system consisting of membrane-bound 
antibodies and fluorescent sFcγRII in solution was used.  Potential nonfluorescent 
competitors were derived from the regions of FcγRII that bind IgG.  The crystal structure 
discussed above (12) and ELISA measurements conducted on FcγRII peptide libraries 
(20) were used as a guide to construct peptides that might compete with sFcγRII to bind 
IgG. 
4.2 Materials and Methods 
4.2.1 Cell Culture 
A Chinese hamster ovary (CHO) cell line, D1959, which secretes sFcγRII, was 
provided by J. C. Unkeless at the Mount Sinai Medical School (21).  The CHO cells were 
grown in Dulbecco’s Modified Eagle Medium (DMEM/F-12) supplemented with 10% 
bovine calf serum, 100 units/mL penicillin, 100 µg/mL streptomycin, 1 mM sodium 
pyruvate, 2 mM L-glutamine and 2 µM methotrexate (Sigma-Aldrich, St. Louis, MO), in 
a humidified incubator at 37 ⁰C under 5% carbon dioxide.  All cell culture reagents were 
of the Gibco® brand (Invitrogen, Carlsbad, CA) unless otherwise stated. 
The mouse IgG1, 1B7.11, was obtained from a hybridoma cell line of the same 
name (American Type Culture Collection, Rockville, MD).  Except for the absence of 
methotrexate, 1B7.11 cells were cultured in the same way as the CHO cells above. 
4.2.2 Purification of sFcγRII 
Soluble FcγRII was purified from the CHO cell supernatant via affinity 
chromatography with 2.4G2-conjugated Sepharose 4B, as previously described (19).  
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(2.4G2 is an antibody against mouse FcγRII.)  The receptor was eluted using 100 mM 
sodium acetate, 150 mM sodium chloride, pH 4.0, and immediately dialyzed against 
PBS.  Purified sFcγRII was stored in PBS at 4 ⁰C. 
4.2.3 Purification of 1B7.11 Antibody 
The 1B7.11 antibody was isolated from the 1B7.11 hybridoma supernatant.  
Briefly, the supernatant was passed over an affinity column consisting of dinitrophenyl-
human serum albumin conjugated to Sepharose 4B (Sigma-Aldrich, St. Louis, MO) (2).  
The antibody was eluted with N-2,4-dinitrophenylglycine (DNP-G; Sigma-Aldrich, St. 
Louis, MO) in phosphate buffered saline (PBS; 50 mM sodium phosphate, 150 mM 
sodium chloride, 0.01 % sodium azide).  The eluant was extensively dialyzed against 
PBS to remove DNP-G.  Anion exchange chromatography was performed to remove 
residual DNP-G.  Briefly, 1B7.11 fractions was dialyzed against an ion exchange buffer 
(10 mM sodium phosphate (monobasic); 100 mM sodium chloride; 0.01 % sodium azide, 
pH 5.7), concentrated and applied to a Dowex 1x8-200 column (5 mL; Acros Organics, 
Morris Plains, NJ).  1B7.11 was eluted using the same ion exchange buffer and 
immediately dialyzed against PBS.  Purified 1B7.11 was stored in PBS at 4 ⁰C. 
4.2.4 Fluorescence Labeling 
Fluorescein isothiocyanate (FITC; Invitrogen, Carlsbad, CA) was used to 
fluorescently label primary amines in sFcγRII and 1B7.11.  A ~5 µM solution of either 
protein in 100 mM sodium bicarbonate, pH 9.2 was incubated with a 25-fold molar 
excess of FITC for 1 h at room temperature.  FITC was initially dissolved in 
dimethylsulfoxide (DMSO) such that in the final reaction mixture there was less than 1% 
(v/v) DMSO.  Gel filtration chromatography using Sephadex G-50 was employed to 
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remove excess dye.  Eluted protein was dialyzed against PBS.  Labeling ratios for 
sFcγRII (~0.5) and 1B7.11 (~1) were determined spectrophotometrically, assuming the 
following molar absorptivities: ε280(1B7.11, IgG) = 210 000 M
-1
 cm
-1, ε280 (sFcγRII) = 33 
000 M
-1
 cm
-1; ε280 (fluorescein) = 75 000 M
-1
 cm
-1
. 
4.2.5 Sample Preparation 
All phospholipids were purchased from Avanti Polar Lipids (Birmingham, AL).  
Aliquots of dinitrophenylaminocaproyl-dipalmitoylphosphatidylethanolamine (DNP-cap-
DPPE) and dipalmitoylphosphatidylcholine (DPPC) at DNP-cap-DPPE molar fractions of 
0 and 0.25 were dried under nitrogen to a thin film.  Residual chloroform was removed 
by centrifuging the mixtures in vacuo overnight.  The dried phospholipids were 
reconstituted in water to make 2 mM phospholipid suspensions.  To make small 
unilamellar vesicles (SUVs), the suspensions were sonicated to clarity.  The vesicle 
suspension was stored in base-cleaned glass vials at room temperature and used within 72 
h.  Immediately prior to use, larger vesicles were pelleted by centrifuging the suspension 
for 30 min at 100,000 g in an air ultracentrifuge (Beckman Instruments, Palo Alto, CA).  
Only the top halves of the centrifuged vesicle suspensions were used (see below).  These 
vesicles had diameters of about 100 nm as measured by dynamic light scattering (DLS). 
Microscope (3 in. x 1 in. x 1 mm; Gold Seal® Products, Porstmouth, NH) and 
fused silica (0.25 in. x 1 in. x 1 mm; Quartz Scientific, Fairport Harbor, OH) slides were 
cleaned by boiling in ICN detergent (MP Biomedicals, Solon, OH) diluted in water.  The 
slides were alternatively bath sonicated for 30 min and rinsed extensively in deionized 
water for two rounds, and dried at 120 ⁰C.  Immediately prior to collecting data, the 
substrates were further cleaned in an argon ion plasma cleaner (PDC-3XG; Harrick 
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Scientific, Ossining, NY) for 15 min at room temperature.  Fused silica slides were 
mounted on microscope slides using double sided, 0.13 mm thick, tape (part no. 021200-
64988; 3M Corp., St. Paul, MN).  The SUV suspension (60 µL) was subsequently 
injected into the sample chamber created by the fused silica substrate and microscope 
cover slip.  The sample slides were incubated at room temperature for an hour to allow 
the SUVs to fuse and form supported planar membranes.  Excess vesicles were removed 
by washing with PBS (10X, 200 µL).  The samples were incubated with ovalbumin (200 
µL, 10 mg/mL) for 30 min to block nonspecific binding sites, prior to the addition of 
saturating amounts of 1B7.11 (200 µL, 9 µM, 30 min).  The sample chambers were again 
washed with PBS (10X, 200 µL) to remove unbound 1B7.11.  Finally, the samples were 
treated with desired concentrations of F-sFcγRII and nonfluorescent competitor. 
 
Figure 4.2:  Through-prism TIRFM. 
4.2.6 TIRFM Instrumentation 
TIRFM was used to verify that 1B7.11 and F-sFcγRII were binding specifically to 
the surface and to measure the equilibrium dissociation constants of these specific 
interactions.  The technique was also used to determine whether the various peptides 
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were behaving as competitors.  Samples were imaged using an inverted fluorescence 
microscope (Zeiss Axiovert 35, Carl Zeiss Microimaging, Thornwood, NY).  A fused 
silica prism was used to totally internally reflect a 488 nm laser beam, generated by an 
argon ion laser (Innova 90-3, Coherent, Palo Alto, CA), at the interface between the fused 
silica substrate and liquid medium, or sample.  The resulting evanescent wave excited 
fluorescence in the 100 nm section of the sample adjacent to the fused silica substrate, as 
shown in Figure 4.2.  A single-photon counting photomultiplier (RCA C31034A, 
Lancaster, PA) was used to detect the emitted fluorescence.  SigmaPlot was used to fit 
the measured fluorescence to appropriate models. 
4.2.7 Experiments 
To determine whether peptides behaved as nonfluorescent competitors, TIRFM 
binding curves were obtained as a function of the peptide concentration at a F-sFcγRII 
concentration that is close to or below the mid-point of the F-sFcγRII/1B7.11 binding 
curve (see Figure 4.7b).  Peptides that compete with F-sFcγRII to bind surface-bound 
1B7.11 cause the surface-associated fluorescence to decrease as a function of the peptide 
concentration.  Resulting curves were fit to the equilibrium binding model shown in Eq. 
4.12: 
 
   cf
f
LKLK
LQK
F
21
1
1 
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to obtain the peptide/1B7.11 association constant K2.  Q, a free parameter, is a 
proportionality constant.  The association constant, K1, pertaining to F-sFcγRII/1B7.11 
binding and the concentration, [Lf], of F-sFcγRII were fixed at their known values. 
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4.3 Results 
4.3.1 Theoretical Work to Find Optimal Experimental Conditions 
To find experimental conditions that would be most likely to yield autocorrelation 
curves containing significant information about both the fluorescent ligand and 
nonfluorescent competitor, we systematically explored the parameter space to find 
conditions that satisfied the criteria defined in section 4.1.1.  Specifically, there are ten 
variables that affect the autocorrelation function: h, d, Rz, S, k-1, k-2, K1, K2, Xf and Xc.  
These variables were assigned a range of values that are typically seen associated with 
them (see Table 1).  The values in Table 1 were used in 4.2-4.11 to find the conditions 
that would allow us to meet the criteria detailed above.  We found that λ1,2 only differ 
from k-1 by a factor of 2 and s1,2 > 0.5 when K1 = 10
7
 M
-1
.  Figure 4.3 shows that the 
autocorrelation function’s dependence on α becomes more pronounced as α decreases.  
Given that α = k-2/k-1 and k-1 = 0.1 s
-1, the shape of G(τ) is most affected by k-2 when k-2 < 
k-1, i.e. when the nonfluorescent competitor binds the surface binding site more tightly 
than the fluorescent ligand.  Furthermore, the effect of the nonfluorescent competitor on 
G(τ) is only seen at long correlation times (τ = ~10-100 s; see Figure 4.3).  To sufficiently 
sample fluorescence fluctuations that occur at these frequencies and thereby, measure k-2, 
we have to monitor the fluorescence over the course of many minutes, possibly hours. 
One potential difficulty is that our samples may not be stable for so long. 
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Table 4.1:  TIR-FCS Variables and Associated Values 
 
h 0.5 µm 
d 0.1 µm 
Rz 4000 s
-1
 
S 1 – 3000 molec µm-2 
k-1 0.1 – 100 s
-1
 
K1 10
4
 – 107 M-1 
Xf (= K1[Lf] 0.01 – 10 
Xc(= K2[Lc] 0.01 – 10 
 
K1 values were obtained from the corresponding range of k-1 values and the assumption that k1 = 
10
6
 M
-1
s
-1
. 
 
 
Figure 4.3:  Sample Autocorrelation Plots with a Significant Dependence on k-2.  
Autocorrelation functions computed using S = 30 molec μm-2, K1 = 10
7
 M
-1
s
-1
, k1 = 10
6
 M
-1
s
-1
, k-1 
= 0.1 s
-1
, Xf = 0.5 and Xc = 5. 
 
As the equilibrium constant for the binding of sFcγRII to IgG is ~106 M-1, TIR-
FCS data will be unlikely to contain significant information about the kinetics of 
nonfluorescent molecules that compete with fluorescent sFcγRII to bind membrane-
bound IgG (see Figure 4.4a).  While TIR-FCS may not allow us to measure rate 
constants, Eq. 4.6 shows that Gs(0) is dependent on Xc and thereby, K2.  Hence, TIR-FCS 
experiments may yet yield equilibrium constants of nonfluorescent competitors 
interacting with membrane-bound receptors (see Figure 4.4b). 
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Figure 4.4:  Sample Autocorrelation Plots with No Significant Dependence on k-2.  
Autocorrelation functions were computed at S = 30 molec μm-2, K1 = 10
6
 M
-1
, k1 = 10
6
 M
-1
s
-1
, k-1 
= 1 s
-1
 and Xf = 0.01.  In (a) Xc = 5 and 0.01 ≤ α ≤ 0.14.  In (b) 0 ≤ Xc ≤ 8 and α = 0.1. 
 
Upon reviewing the criteria, we think we would get a better indication of whether 
the autocorrelation function contains significant information about k-2 by comparing rates 
obtained in the presence and absence of nonfluorescent competitors.  Therefore, we will 
define the conditions where either λ1’s or λ2’s obtained in the presence and absence of 
competitor differ by a factor of 2 and the amplitudes associated with these rates are 
significant.  This new criterion may change our understanding so that the conditions for 
which k-2 can be measured are broader.  Reducing the fraction of fluorescently labeled 
reporter may further increase the conditions under which we can obtain k-2. 
4.3.2 Experimental Work to Establish the Model System 
To test the nonfluorescent competitor theory, we wanted to establish a model 
system in which nonfluorescent molecules compete with the fluorescently labeled 
soluble, extracellular portion of FcγRII to bind the anti-DNP IgG, 1B7.11, immobilized 
on DNP-cap-DPPE – containing supported planar membranes (see Figure 4.5).  Detailed 
below is the progress that has been made in realizing this system. 
 
a b 
126 
 
 
Figure 4.5:  Schematic of Experimental System.  Nonfluorescent competitors compete with F-
sFcγRII to bind membrane-bound 1B7.11.  The solid phase membrane is made of phospholipids, 
DNP-cap-DPPE and DPPC (see below).  The green background represents the evanescent wave 
produced by TIR illumination. 
 
4.3.2.1 1B7.11 was specifically immobilized on DNP-cap-DPPE – containing 
supported planar membranes. 
The mouse IgG1, 1B7.11, is an antibody against trinitrophenyl (TNP).  As TNP-
conjugated phospholipids are not commercially available, 1B7.11 was immobilized on 
membranes containing dinitrophenylaminocaproyl-dipalmitoylphosphatidylethanolamine 
(DNP-cap-DPPE).  The specificity of fluorescently labeled 1B7.11 (F-1B7.11) for solid-
phase membranes containing 25 mole per cent DNP-cap-DPPE and 75 mole per cent 
dipalmitoylphosphatidylcholine (DPPC) was examined using TIRFM.  The surface-
associated fluorescence of DNP-cap-DPPE/DPPC membranes treated with F-1B7.11 and 
washed with PBS was significantly higher than that of DPPC membranes treated with F-
1B7.11 (Figure 4.6).  These results show that F-1B7.11 binds specifically to DNP-cap-
DPPE/DPPC membranes.  In membranes with 25 mole per cent DNP-cap-DPPE, 9 μM 
F-1B7.11 saturated 1B7.11 binding sites on the membrane. 
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Figure 4.6: Binding of F-1B7.11 to DNP-cap-DPPE/DPPC Planar Membranes. (a) 
Normalized surface-associated fluorescence of DNP-cap-DPPE/DPPC (25:75, mol:mol) (
⁰
) and 
DPPC (•) membranes treated with F-1B7.11 and washed.  The data for the DPPC membranes 
were fit to a line.  (b) Normalized fluorescence obtained by subtracting the DPPC data from the 
data associated with DNP-cap-DPPE/DPPC membranes. 
 
4.3.2.2 F-sFcγRII binds specifically to membrane-bound 1B7.11. 
TIRFM was used to obtain binding curves for the association of F-sFcγRII and 
membrane-bound 1B7.11.  DNP-cap-DPPE/DPPC (25:75, mol:mol) membranes were 
treated with saturating amounts of 1B7.11 (9 μM) and washed.  The surface-associated 
fluorescence of 1B7.11-coated membranes was measured as a function of F-sFcγRII 
concentration (Figure 4.7a).  The fluorescence of DNP-cap-DPPE/DPPC membranes that 
had not been treated with 1B7.11 was also measured as a function of F-sFcγRII 
concentration (Figure 4.7a).  The difference in fluorescence between the 1B7.11-treated 
and –untreated membranes as a function of F-sFcγRII concentration, seen in Figure 4.7b, 
has the appearance of a conventional binding isotherm.  This plot was fit to a model of 
reversible, bimolecular binding given by 
 
 AK
A
F
F
d 

max
,         4.13 
a b 
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Where F/Fmax is the normalized fluorescence, [A] is the concentration of the fluorescent 
ligand and Kd is the dissociation constant.  The free parameters were Kd and Fmax.  It was 
determined that F-sFcγRII binds 1B7.11 with a dissociation constant of 1.1±0.4 μM.  
This value is consistent with dissociation constants obtained for the binding of sFcγRII 
and another membrane-bound mouse IgG, GK14.1 (19).  It is approximately equivalent 
to dissociation constants obtained for IgG in solution and FcγRII reconstituted in planar 
membranes (2, 16-18). 
a b 
 
Figure 4.7:  Equilibrium Binding of F-sFcγRII to 1B7.11-Coated DNP-cap-DPPE/DPPC 
Membranes. (a) Normalized surface-associated fluorescence of samples containing F-sFcγRII in 
the presence (⁰) and absence (•) of membrane-bound 1B7.11.  The data from membranes with no 
1B7.11 were fit to a line.  (b) Normalized fluorescence associated with 1B7.11-bound F-sFcγRII, 
obtained by subtracting theoretical values from the line in (a) from the fluorescence data for 
membranes with 1B7.11.  The difference data were fit to a one-site binding model, which yielded 
the equilibrium dissociation constant (K
d
=1.1±0.4 µM). 
 
4.3.2.3 Identification of peptide that competes with F-sFcγRII to bind 
1B7.11 immobilized on supported planar membranes. 
Several mutagenesis studies and crystal structures have identified three loops 
(B/C, C’/E and F/G) in the immunoglobulin domain, D2, of Fcγ receptors that are 
responsible for binding IgGs (11-15).  ELISA measurements showed that two peptides 
derived from the B/C and F/G loops inhibit the binding of immune complexes to sFcγRII 
a b 
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(20).  Hence, we had these two peptides (HSWRNKLLNR (peptide A) and 
KGSLGRTLHQSK (peptide B)) synthesized at the Microprotein Sequencing & Peptide 
Synthesis Facility at UNC-CH.  A third peptide, HSWRNKLLNRISFFHNEKSVR-
YHHYS (peptide C), that contains residues from both B/C and C’/E loops was also 
synthesized.  TIRFM experiments were used to confirm whether these peptides inhibit 
the binding of F-sFcγRII to 1B7.11. 
TIRFM was used to measure the surface-associated fluorescence of 1B7.11-coated 
membranes treated with 1.5 μM F-sFcγRII, as a function of nonfluorescent competitor 
concentration.  Measurements of the surface-associated fluorescence of 1B7.11-coated 
membranes with 1.5 μM F-sFcγRII, as a function of the unlabeled sFcγRII concentration, 
show a nice monotonic decrease, as would be expected for a nonfluorescent competitor 
(Figure 4.8).  However, the fluorescence associated with 1B7.11-coated membranes and 
F-sFcγRII did not decrease with increasing concentrations of peptide A, peptide B or a 
mixture of the two (data not shown).  These results indicate that peptides A and B failed 
to compete with F-sFcγRII to bind 1B7.11.  This outcome is unexpected as ELISA 
experiments showed both peptides inhibit the binding of immune complexes to sFcγRII 
(20).  As peptides A and B only contain residues from one of the three loops that are 
thought to form the IgG binding site on FcγRII, it is possible that they alone cannot block 
the FcγRII binding site on 1B7.11, and thereby prevent F-sFcγRII from binding the 
membrane-bound receptor. 
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Figure 4.8:  Control Measurements with Nonfluorescent sFcγRII.  Equilibrium binding 
curves of 1.5 μM F-sFcγRII and 1B7.11 obtained as function of sFcγRII. 
 
Peptide C, which contains residues from two of the three important loops, was 
insoluble in PBS (0.05 M sodium phosphate, 0.15 M NaCl, 0.01% NaN3) at pH 7.4. 
Peptide C dissolved when the pH of the buffer was lowered to ~6.3.  TIRFM 
experiments, conducted in PBS at pH 6.3, showed that the fluorescence of F-sFcγRII 
interacting with membrane-bound 1B7.11 did not decrease with increasing concentrations 
of peptide C (data not shown).  However, when the same experiments were conducted in 
conditions of low salt (0.01 M sodium phosphate, 0.03 M NaCl, 0.01% NaN3, pH 6.3), 
the fluorescence decreased, indicating peptide C successfully blocked F-sFcγRII from 
binding 1B7.11 (see Figure 4.9).  However, it was observed that at such low salt 
concentrations, F-sFcγRII bound nonspecifically to DNP-cap-DPPE/DPPC membranes 
that had not been treated with 1B7.11 (data not shown).  Therefore, this design of a 
negative control measurement of the specificity may not be adequate for low salt 
conditions.  Instead, replicating the data shown in Figure 4.8 with the new solution 
conditions might be a better strategy.  An alternate approach may include modifying the 
peptide sequence to increase its solubility at the higher pH and salt concentration, while 
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retaining its ability to compete with sFcγRII to bind 1B7.11.  The use of organic co-
solvents such a DMSO or dimethyl formamide (DMF) might also be a viable option. 
 
Figure 4.9:  Nonfluorescent Peptide Competing with F- sFcγRII.  Equilibrium binding curve 
of 0.8 μM F-sFcγRII and 1B7.11 obtained as a function of peptide C.  The data were fit to the 
binding model in Eq. 4.14 to obtain K
2
 (K
2
 = 0.6 ± 0.2 μM
-1
). 
 
4.4 Conclusion 
Progress was made towards identifying experimental conditions that are likely to 
yield autocorrelation curves containing significant kinetic information about 
nonfluorescent competitors.  Towards this end, criteria that need to be satisfied to obtain 
informative autocorrelation curves were defined.  Nonfluorescent competitor theory was 
systematically explored to identify experimental conditions that would satisfy the 
predetermined criteria.  Few experimental conditions were found to meet all the criteria.  
In reviewing the criteria, however, it was determined that some of the criteria may not 
necessarily lead to the acquisition of data that contain significant kinetic information 
about nonfluorescent competitors.  As a result, new criteria have been proposed.  The 
theory will have to be revisited with these new criteria in mind to find optimal 
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experimental conditions that are likely to yield data from which kinetic information about 
nonfluorescent competitors can be extracted. 
Work was conducted to establish a nonfluorescent competitor test system 
consisting of the IgG, 1B7.11, and the soluble portion of the Fc receptor, FcγRII.  1B7.11 
was specifically immobilized on solid-phase, supported planar membranes.  TIRFM 
measurement showed that F-sFcγRII specifically binds membrane-bound 1B7.11 with a 
binding constant of 1.1±0.4 μM, a value that is consistent with that obtained by Gesty-
Palmer and Thompson (27).  Additionally, TIRFM binding isotherms showed that 
unlabeled sFcγRII inhibits the binding of F-sFcγRII to membrane-bound 1B7.11.  These 
experiments demonstrate that the system behaves as expected.  Additionally, a peptide 
that appears to compete with F-sFcγRII to bind membrane-bound 1B7.11 was identified.  
However, if this peptide is to be used to test the nonfluorescent competitor theory, the 
model system at this point requires some further optimization. 
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Chapter 5 
 
Summary and Future Directions 
 
Theoretical work was conducted to ease the implementation of TIR-FCS with 
respect to its application to the study of ligand-receptor interactions (Chapter 2, (1)).  
Autocorrelation curves depend on numerous experimental parameters that are unique to 
either the particular instrumental setup or biological system.  This rather large parameter 
space complicates the identification of experimental conditions that are likely to yield 
autocorrelation curves with good signal-to-noise ratios, containing significant 
information about the thermodynamic and kinetic parameters of interest.  To address this 
difficulty, criteria, that need to be satisfied in order to obtain informative autocorrelation 
curves, were defined.  Parameter space was systematically explored to identify 
experimental conditions under which these criteria would be satisfied.  This work 
additionally serves as a general guide to define criteria and identify experimental 
conditions for TIR-FCS measurements of ligand-receptor interactions. 
Theoretical work has also suggested that TIR-FCS can yield kinetic information 
about nonfluorescent effectors and competitors (2, 3).  To test these theoretical 
predictions, work was conducted to establish model systems containing a nonfluorescent 
effector (Chapter 3, (4)) and nonfluorescent competitor (Chapter 4).  The nonfluorescent 
effector test system was to consist of the pregnane X receptor (PXR), peptides derived 
from co-activator and co-repressor proteins, and a PXR ligand, rifampicin.  In the process 
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of establishing this system, it was determined that the mechanism of PXR action differs 
from that of other nuclear receptors.  Namely, the PXR ligand, rifampicin, does not 
enhance the receptor’s affinity for co-activator or reduce PXR’s affinity for co-repressors 
(4).  These results are of great biological significance, and present many avenues for 
further study.  Needless to say, rifampicin is not an effector, and this system cannot be 
used to test theory pertaining to nonfluorescent effectors.  However, it was shown that co-
activator and co-repressor peptides compete with each other to bind PXR (4), thereby, 
allowing the system to serve as a test system for nonfluorescent competitors. 
 It was originally thought that a model system consisting of an IgG and the mouse 
Fc receptor, FcγRII, could be used to test nonfluorescent competitor theory (Chapter 4).  
In establishing this system, IgG were immobilized on supported planar membranes via 
their hapten binding site, while the soluble, extracellular portion of FcγRII (sFcγRII) was 
fluorescently labeled.  As a competitor had not been previously identified for this system, 
we thought to engineer a competitor by designing peptides from the antibody binding site 
on FcγRII.  Of the three peptides that were synthesized, one competed with fluorescent 
sFcγRII to bind surface-associated IgG.  For reasons discussed in Chapter 4, this system 
would require further optimization before it could be fully implemented for the purposes 
of testing nonfluorescent competitor theory. 
Theoretical work was also conducted to identify experimental conditions that 
would increase the likelihood of obtaining autocorrelation curves containing significant 
information about nonfluorescent competitors (Chapter 4).  As in Chapter 2, criteria were 
defined that, if satisfied, would yield kinetic information about nonfluorescent 
competitors.  The parameter space was then explored to identify experimental conditions 
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that meet these criteria.  A limited number of experimental conditions that satisfy all the 
criteria were found.  However, the criteria have since been refined to better reflect the 
requirements for obtaining autocorrelation curves containing relevant information.  
Parameter space has yet to be explored in light of these new criteria to determine 
allowable experimental conditions.  Upon completing this theoretical work, the PXR, co-
activator and co-repressor system established here can be used to test the experimental 
conditions. 
Parallel work will have to be conducted for nonfluorescent effectors.  Theoretical 
work will be conducted to determine experimental conditions under which kinetic 
information about nonfluorescent effectors can be obtained.  A model system will have to 
be established to test these experimental conditions.  The most obvious candidate system 
would consist of another nuclear receptor like the estrogen receptor, where the agonist 
(estrogen) has been shown to increase the affinity of the receptor for the relevant co-
activator.  Extending TIR-FCS to the study of nonfluorescent species will be a major 
advancement, allowing the technique to be used to study biological systems containing 
compounds that are not readily amenable to fluorescence labeling. 
In the immediate future, however, the application of TIR-FCS to the study of 
simple, bimolecular interactions will be fully characterized.  In fact, PXR and the SRC-1 
peptide are currently being used to test the experimental conditions that were predicted to 
yield informative autocorrelation curves in Chapter 2.  Specifically, autocorrelation 
curves are being obtained for PXR/F-SRC-1 interactions within a range F-SRC-1 
concentrations, PXR surface site densities and pin hole sizes that are thought to satisfy 
the criteria that were defined in Chapter 2.  Preliminary data agree with theoretical 
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predictions.  For instance, G(0) values were found to increase with decreasing F-SRC-1 
concentrations, as would be expected for variables that are inversely related.  Similarly, 
G(0) values measured in the presence of PXR are lower than corresponding G(0) values 
obtained in the absence of PXR, as binding causes an increase in the apparent, local 
concentration of fluorescent ligand.  When Gneg(0) versus F-SRC-1 concentrations are fit 
to an appropriate functional form, h values of ~1 µm are obtained as would be expected 
given a 50 µm pin hole and the magnification of the microscope.  Similarly, when Gpos(0) 
versus F-SRC-1 concentrations are fit to an appropriate theoretical form, surface site 
densities were obtained.  These values agreed with those that had been obtained from 
TIRFM binding isotherms (see Chapter 3).  Gneg(0) and Gpos(0) refer to G(0) values that 
were obtained in the absence and presence of PXR.  Additionally, off rates of about 5 s
-1
 
were obtained for PXR/F-SRC-1 interactions.  These values are within the same order of 
magnitude as those obtained using TIR-FRAP (2 s
-1
; Chapter 3).  The off rates are also 
independent of the F-SRC-1 concentration, indicating that rebinding is negligible. 
In the long term, TIR-FCS will be transformed into a high-throughput technique 
by introducing appropriate microfluidic devices and high-speed imaging cameras.  In 
addition, the technique can be applied to the study of live-cells.  For instance, TIR-FCS 
can be used to build kinetic maps of specific ligand-receptor interactions in cells.  TIRFM 
combined with fluorescence cross-correlation spectroscopy will facilitate the study of 
multiple fluorescently labeled species. 
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